false--12-31 Q2 2023 0001665300 33.33 33.33 0001665300 2023-01-01 2023-06-30 0001665300 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001665300 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001665300 2023-08-11 xbrli:shares 0001665300 2023-06-30 iso4217:USD 0001665300 2022-12-31 iso4217:USD xbrli:shares 0001665300 2023-04-01 2023-06-30 0001665300 2022-04-01 2022-06-30 0001665300 2022-01-01 2022-06-30 0001665300 us-gaap:CommonStockMember 2023-03-31 0001665300 us-gaap:TreasuryStockCommonMember 2023-03-31 0001665300 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001665300 us-gaap:RetainedEarningsMember 2023-03-31 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001665300 2023-03-31 0001665300 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001665300 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001665300 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001665300 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001665300 us-gaap:CommonStockMember 2023-06-30 0001665300 us-gaap:TreasuryStockCommonMember 2023-06-30 0001665300 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001665300 us-gaap:RetainedEarningsMember 2023-06-30 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001665300 us-gaap:CommonStockMember 2022-12-31 0001665300 us-gaap:TreasuryStockCommonMember 2022-12-31 0001665300 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001665300 us-gaap:RetainedEarningsMember 2022-12-31 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001665300 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001665300 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001665300 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0001665300 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001665300 us-gaap:CommonStockMember 2022-03-31 0001665300 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001665300 us-gaap:RetainedEarningsMember 2022-03-31 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001665300 2022-03-31 0001665300 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001665300 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001665300 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001665300 us-gaap:CommonStockMember 2022-06-30 0001665300 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001665300 us-gaap:RetainedEarningsMember 2022-06-30 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001665300 2022-06-30 0001665300 us-gaap:CommonStockMember 2021-12-31 0001665300 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001665300 us-gaap:RetainedEarningsMember 2021-12-31 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001665300 2021-12-31 0001665300 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001665300 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001665300 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001665300 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001665300 phun:DigitalAssetsMember 2023-06-30 0001665300 phun:DigitalAssetsMember 2022-12-31 0001665300 us-gaap:AccountsReceivableMember phun:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 xbrli:pure 0001665300 us-gaap:AccountsReceivableMember phun:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001665300 us-gaap:AccountsReceivableMember phun:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001665300 us-gaap:AccountsReceivableMember phun:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001665300 us-gaap:AccountsReceivableMember phun:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001665300 us-gaap:AccountsReceivableMember phun:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 phun:reportingUnit 0001665300 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001665300 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001665300 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001665300 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001665300 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001665300 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001665300 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-06-30 0001665300 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-06-30 0001665300 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001665300 us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001665300 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001665300 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001665300 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001665300 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001665300 phun:MeasurementInputStrikePriceMember us-gaap:WarrantMember 2023-06-30 0001665300 phun:MeasurementInputStrikePriceMember us-gaap:WarrantMember 2022-12-31 0001665300 us-gaap:WarrantMember us-gaap:MeasurementInputSharePriceMember 2023-06-30 0001665300 us-gaap:WarrantMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001665300 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-06-30 0001665300 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001665300 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-06-30 0001665300 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001665300 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-06-30 0001665300 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001665300 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2023-06-30 0001665300 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2022-12-31 0001665300 phun:PlatformRevenueMember 2023-04-01 2023-06-30 0001665300 phun:PlatformRevenueMember 2022-04-01 2022-06-30 0001665300 phun:PlatformRevenueMember 2023-01-01 2023-06-30 0001665300 phun:PlatformRevenueMember 2022-01-01 2022-06-30 0001665300 phun:HardwareRevenuesMember 2023-04-01 2023-06-30 0001665300 phun:HardwareRevenuesMember 2022-04-01 2022-06-30 0001665300 phun:HardwareRevenuesMember 2023-01-01 2023-06-30 0001665300 phun:HardwareRevenuesMember 2022-01-01 2022-06-30 0001665300 us-gaap:SalesRevenueNetMember country:US us-gaap:GeographicConcentrationRiskMember 2023-04-01 2023-06-30 0001665300 us-gaap:SalesRevenueNetMember country:US us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-06-30 0001665300 us-gaap:SalesRevenueNetMember country:US us-gaap:GeographicConcentrationRiskMember 2022-04-01 2022-06-30 0001665300 us-gaap:SalesRevenueNetMember country:US us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-06-30 0001665300 phun:PlatformRevenueMember 2023-06-30 0001665300 phun:PlatformRevenueMember 2022-12-31 0001665300 phun:HardwareRevenuesMember 2023-06-30 0001665300 phun:HardwareRevenuesMember 2022-12-31 0001665300 2023-07-01 2023-06-30 phun:phunToken 0001665300 phun:BitcoinMember 2023-06-30 0001665300 phun:EthereumMember 2023-06-30 0001665300 phun:OtherDigitalAssetsMember 2023-06-30 0001665300 phun:BitcoinMember 2022-12-31 0001665300 phun:EthereumMember 2022-12-31 0001665300 phun:OtherDigitalAssetsMember 2022-12-31 0001665300 phun:BitcoinMember 2023-01-01 2023-06-30 0001665300 phun:EthereumMember 2023-01-01 2023-06-30 0001665300 phun:OtherDigitalAssetsMember 2023-01-01 2023-06-30 0001665300 phun:A2022PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2022-07-06 0001665300 phun:A2022PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2022-07-06 2022-07-06 0001665300 phun:A2022PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2023-03-15 2023-03-15 0001665300 phun:A2022PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2023-06-30 0001665300 phun:A2022PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2022-12-31 0001665300 phun:AtMarketIssuanceSalesAgreementMember 2022-01-31 0001665300 phun:AtMarketIssuanceSalesAgreementMember 2022-01-31 2022-01-31 0001665300 phun:AtMarketIssuanceSalesAgreementMember 2022-02-01 2022-02-01 0001665300 phun:WainwrightSalesAgreementMember 2023-01-01 2023-06-30 0001665300 2023-01-05 0001665300 phun:ConvertibleNoteWarrantsMember 2023-06-30 0001665300 phun:ConvertibleNoteWarrantsMember 2022-12-31 0001665300 phun:CommonStockWarrantsMember 2023-06-30 0001665300 phun:CommonStockWarrantsMember 2022-12-31 0001665300 phun:PublicWarrantsMember 2023-06-30 0001665300 phun:PublicWarrantsMember 2022-12-31 0001665300 phun:PrivatePlacementWarrantsMember 2023-06-30 0001665300 phun:PrivatePlacementWarrantsMember 2022-12-31 0001665300 phun:UnitPurchaseOptionWarrantsMember 2023-06-30 0001665300 phun:UnitPurchaseOptionWarrantsMember 2022-12-31 0001665300 us-gaap:WarrantMember 2020-12-31 0001665300 us-gaap:WarrantMember us-gaap:CommonStockMember 2020-12-31 0001665300 us-gaap:WarrantMember us-gaap:CommonStockMember 2021-02-28 0001665300 us-gaap:WarrantMember 2021-02-28 0001665300 us-gaap:WarrantMember 2021-10-31 0001665300 us-gaap:WarrantMember 2020-10-27 0001665300 us-gaap:WarrantMember 2022-04-30 0001665300 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001665300 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001665300 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001665300 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001665300 us-gaap:SellingAndMarketingExpenseMember 2023-04-01 2023-06-30 0001665300 us-gaap:SellingAndMarketingExpenseMember 2022-04-01 2022-06-30 0001665300 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-06-30 0001665300 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-06-30 0001665300 us-gaap:GeneralAndAdministrativeExpenseMember 2023-04-01 2023-06-30 0001665300 us-gaap:GeneralAndAdministrativeExpenseMember 2022-04-01 2022-06-30 0001665300 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-06-30 0001665300 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-06-30 0001665300 us-gaap:ResearchAndDevelopmentExpenseMember 2023-04-01 2023-06-30 0001665300 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0001665300 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-06-30 0001665300 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001665300 phun:PhunwareInc2023InducementPlanMember 2023-06-30 0001665300 phun:PhunwareInc2022InducementPlanMember 2023-06-30 0001665300 phun:TwoThousandEighteenStockOptionAndIncentivePlanMember 2023-06-30 0001665300 phun:TwoThousandEighteenEmployeeStockPurchasePlanMember 2023-06-30 0001665300 phun:TwoThousandNineStockOptionAndIncentivePlanMember 2023-06-30 0001665300 phun:PhunwareInc2023InducementPlanMember 2023-01-01 2023-06-30 0001665300 phun:PhunwareInc2022InducementPlanMember 2023-01-01 2023-06-30 0001665300 phun:TwoThousandEighteenStockOptionAndIncentivePlanMember 2023-01-01 2023-06-30 0001665300 phun:TwoThousandEighteenEmployeeStockPurchasePlanMember 2023-01-01 2023-06-30 0001665300 phun:TwoThousandNineStockOptionAndIncentivePlanMember 2023-01-01 2023-06-30 0001665300 phun:PhunwareInc2023InducementPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 2023-06-30 0001665300 srt:ScenarioForecastMember phun:PhunwareInc2023InducementPlanMember us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember 2025-06-02 2026-06-01 phun:annual 0001665300 phun:PhunwareInc2022InducementPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-31 0001665300 srt:ScenarioForecastMember phun:PhunwareInc2022InducementPlanMember us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember 2023-12-28 2023-12-28 0001665300 srt:ScenarioForecastMember phun:PhunwareInc2022InducementPlanMember us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 2025-12-28 phun:quarter 0001665300 phun:TwoThousandEighteenStockOptionAndIncentivePlanMember 2022-12-31 0001665300 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001665300 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001665300 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001665300 us-gaap:RestrictedStockUnitsRSUMember phun:TeamMembersMember 2023-01-01 2023-03-31 0001665300 us-gaap:RestrictedStockUnitsRSUMember phun:TeamMembersMember 2023-03-31 0001665300 us-gaap:RestrictedStockUnitsRSUMember phun:TeamMembersMember 2022-01-01 2022-12-31 0001665300 us-gaap:RestrictedStockUnitsRSUMember phun:TeamMembersMember 2022-12-31 0001665300 us-gaap:RestrictedStockUnitsRSUMember phun:TeamMembersMember 2023-04-01 2023-06-30 0001665300 us-gaap:RestrictedStockUnitsRSUMember phun:TeamMembersMember 2023-06-30 0001665300 phun:TwoThousandEighteenStockOptionAndIncentivePlanMember 2022-01-01 2022-12-31 0001665300 phun:TwoThousandEighteenEmployeeStockPurchasePlanMember 2022-12-31 0001665300 phun:A2009EquityIncentivePlanMember 2022-12-31 0001665300 phun:A2009EquityIncentivePlanMember 2022-01-01 2022-12-31 0001665300 phun:A2009EquityIncentivePlanMember 2023-01-01 2023-06-30 0001665300 phun:A2009EquityIncentivePlanMember 2023-06-30 0001665300 srt:ScenarioForecastMember phun:PhunwareInc2023InducementPlanMember us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember 2024-06-03 2024-06-03 phun:segment 0001665300 phun:PhunwareSegmentMember 2023-04-01 2023-06-30 0001665300 phun:LyteSegmentMember 2023-04-01 2023-06-30 0001665300 phun:PhunwareSegmentMember 2022-04-01 2022-06-30 0001665300 phun:LyteSegmentMember 2022-04-01 2022-06-30 0001665300 phun:PhunwareSegmentMember 2023-01-01 2023-06-30 0001665300 phun:LyteSegmentMember 2023-01-01 2023-06-30 0001665300 phun:PhunwareSegmentMember 2022-01-01 2022-06-30 0001665300 phun:LyteSegmentMember 2022-01-01 2022-06-30 0001665300 phun:PhunwareSegmentMember 2023-06-30 0001665300 phun:LyteSegmentMember 2023-06-30 0001665300 phun:PhunwareSegmentMember 2022-12-31 0001665300 phun:LyteSegmentMember 2022-12-31 0001665300 phun:AtMarketIssuanceSalesAgreementMember us-gaap:SubsequentEventMember 2023-07-01 2023-08-14 0001665300 phun:TeamMembersAndServiceProvidersMember us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-08-14 0001665300 us-gaap:SubsequentEventMember phun:A2022PromissoryNoteMember srt:MinimumMember us-gaap:NotesPayableOtherPayablesMember 2023-08-14 2023-08-14 0001665300 us-gaap:SubsequentEventMember phun:A2022PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2023-08-14 2023-08-14 0001665300 us-gaap:SubsequentEventMember phun:A2022PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2023-08-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-37862
PHUNWARE, INC.
(Exact name of registrant as specified in its charter)

Delaware |  | 30-1205798
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)

1002 West Avenue, Austin, Texas |  | 78701
(Address of principal executive offices) |  | (Zip Code)

Registrant’s telephone number, including area code: 512-693-4199
Securities registered pursuant to Section 12(b) of the Act:

Title of each class: |  | Trading Symbol(s) |  | Name of each exchange on which registered:
Common Stock, par value $0.0001 per share |  | PHUN |  | The NASDAQ Capital Market
Warrants to purchase one share of Common Stock |  | PHUNW |  | The NASDAQ Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☐ | Accelerated filer | ☐
Non-accelerated filer | ☒ | Smaller reporting company | ☒
| Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of August 11, 2023, 120,355,584 shares of common stock, par value $0.0001 per share, were outstanding.

TABLE OF CONTENTS

|  | PAGE
PART I | FINANCIAL INFORMATION | 1
Item 1. | Financial Statements | 1
| Condensed Consolidated Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022 | 2
| Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2023 and 2022 (unaudited) | 3
| Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended June 30, 2023 and 2022 (unaudited) | 4
| Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (unaudited) | 6
| Notes to the Unaudited Condensed Consolidated Financial Statements | 8
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 25
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 38
Item 4. | Controls and Procedures | 39
PART II | OTHER INFORMATION | 40
Item 1. | Legal Proceedings | 40
Item 1A. | Risk Factors | 40
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 41
Item 3. | Defaults Upon Senior Securities | 41
Item 4. | Mine Safety Disclosures | 41
Item 5. | Other Information | 41
Item 6. | Exhibits | 42
| Signatures | 43

i

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report (the “Report”) includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this Report, including statements regarding our future results of operations and financial position, business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These risks and others described under “Risk Factors” may not be exhaustive.
By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in this Report. In addition, even if our results of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in this Report, those results or developments may not be indicative of results or developments in subsequent periods.
ii

Table of Contents
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements
1

Table of Contents
Phunware, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share information)

| June 30, 2023 |  | December 31, 2022
| (Unaudited) |  |
Assets |  |  |
Current assets: |  |  |
Cash | $ | 1,105 |  |  | $ | 1,955 |
Accounts receivable, net of allowance for doubtful accounts of $100 and $198 at June 30, 2023 and December 31, 2022, respectively | 863 |  |  | 958 |
Inventory | 2,168 |  |  | 2,780 |
Digital assets | 71 |  |  | 10,137 |
Prepaid expenses and other current assets | 624 |  |  | 1,033 |
Total current assets | 4,831 |  |  | 16,863 |
Property and equipment, net | 188 |  |  | 221 |
Goodwill | 29,956 |  |  | 31,113 |
Intangible assets, net | 2,190 |  |  | 2,524 |
Right-of-use asset | 3,258 |  |  | 3,712 |
Other assets | 367 |  |  | 402 |
Total assets | $ | 40,790 |  |  | $ | 54,835 |
Liabilities and stockholders’ equity |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 8,350 |  |  | $ | 7,699 |
Accrued expenses | 1,542 |  |  | 2,895 |
Lease liability | 968 |  |  | 954 |
Deferred revenue | 1,092 |  |  | 2,904 |
PhunCoin deposits | 1,202 |  |  | 1,202 |
Current maturities of long-term debt, net | 6,094 |  |  | 9,667 |
Warrant liability | — |  |  | 256 |
Total current liabilities | 19,248 |  |  | 25,577 |
Deferred revenue | 1,050 |  |  | 1,274 |
Lease liability | 2,584 |  |  | 3,103 |
Total liabilities | 22,882 |  |  | 29,954 |
Commitments and contingencies (Note 8) |  |  |
Stockholders’ equity |  |  |
Common stock, $0.0001 par value; 1,000,000,000 shares authorized; 107,565,124 shares issued and 107,058,624 shares outstanding as of June 30, 2023 and 103,153,337 shares issued and outstanding as of December 31, 2022, respectively | 11 |  |  | 10 |
Treasury stock at cost; 506,500 and 0 shares at June 30, 2023 and December 31, 2022, respectively | (502) |  |  | — |
Additional paid-in capital | 279,837 |  |  | 275,562 |
Accumulated other comprehensive loss | (426) |  |  | (472) |
Accumulated deficit | (261,012) |  |  | (250,219) |
Total stockholders’ equity | 17,908 |  |  | 24,881 |
Total liabilities and stockholders’ equity | $ | 40,790 |  |  | $ | 54,835 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2

Table of Contents
Phunware, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except per share information)
(Unaudited)

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Net revenues | $ | 3,487 |  |  | $ | 5,485 |  |  | $ | 8,234 |  |  | $ | 12,263 |
Cost of revenues | 3,031 |  |  | 3,965 |  |  | 7,417 |  |  | 8,972 |
Gross profit | 456 |  |  | 1,520 |  |  | 817 |  |  | 3,291 |
Operating expenses: |  |  |  |  |  |  |
Sales and marketing | 1,472 |  |  | 1,928 |  |  | 2,600 |  |  | 3,413 |
General and administrative | 4,766 |  |  | 5,251 |  |  | 9,478 |  |  | 9,556 |
Research and development | 1,212 |  |  | 1,876 |  |  | 2,984 |  |  | 2,879 |
Impairment of goodwill | 1,203 |  |  | — |  |  | 1,203 |  |  | — |
Total operating expenses | 8,653 |  |  | 9,055 |  |  | 16,265 |  |  | 15,848 |
Operating loss | (8,197) |  |  | (7,535) |  |  | (15,448) |  |  | (12,557) |
Other income (expense): |  |  |  |  |  |  |
Interest expense | (553) |  |  | (273) |  |  | (1,090) |  |  | (654) |
Impairment of digital assets | — |  |  | (12,158) |  |  | (50) |  |  | (21,511) |
Gain on sale of digital assets | 2,096 |  |  | 168 |  |  | 5,310 |  |  | 194 |
Fair value adjustment of warrant liability | 3 |  |  | 2,682 |  |  | 256 |  |  | 2,469 |
Other income, net | 127 |  |  | 45 |  |  | 229 |  |  | 71 |
Total other income (expense), net | 1,673 |  |  | (9,536) |  |  | 4,655 |  |  | (19,431) |
Loss before taxes | (6,524) |  |  | (17,071) |  |  | (10,793) |  |  | (31,988) |
Income tax expense | — |  |  | — |  |  | — |  |  | — |
Net loss | (6,524) |  |  | (17,071) |  |  | (10,793) |  |  | (31,988) |
Other comprehensive income (loss): |  |  |  |  |  |  |
Cumulative translation adjustment | 23 |  |  | (85) |  |  | 46 |  |  | (117) |
Comprehensive loss | $ | (6,501) |  |  | $ | (17,156) |  |  | $ | (10,747) |  |  | $ | (32,105) |
Loss per share, basic and diluted | $ | (0.06) |  |  | $ | (0.17) |  |  | $ | (0.10) |  |  | $ | (0.33) |
Weighted-average common shares used to compute loss per share, basic and diluted | 105,133 |  |  | 97,742 |  |  | 104,151 |  |  | 97,293 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3

Table of Contents
Phunware, Inc.
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(In thousands)
(Unaudited)

| Common Stock |  | Treasury stock |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Other Comprehensive Loss |  | Total Stockholders’ Equity
| Shares |  | Amount |  | Shares |  | Amount |  |  |  |
Balance - March 31, 2023 | 104,470 |  |  | $ | 10 |  |  | (462) |  |  | $ | (475) |  |  | $ | 277,303 |  |  | $ | (254,488) |  |  | $ | (449) |  |  | $ | 21,901 |
Release of restricted stock | 1,287 |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |
Issuance of common stock under the 2018 employee stock purchase plan | 93 |  |  | — |  |  | — |  |  | — |  |  | 47 |  |  | — |  |  | — |  |  | 47 |
Sales of common stock, net of issuance cost | 1,715 |  |  | — |  |  | — |  |  | — |  |  | 995 |  |  | — |  |  | — |  |  | 995 |
Stock-based compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | 1,492 |  |  | — |  |  | — |  |  | 1,492 |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 23 |  |  | 23 |
Treasury stock repurchase | — |  |  | — |  |  | (45) |  |  | (27) |  |  | — |  |  | — |  |  | — |  |  | (27) |
Net loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (6,524) |  |  | — |  |  | (6,524)
Balance - June 30, 2023 | 107,565 |  |  | $ | 11 |  |  | (507) |  |  | $ | (502) |  |  | $ | 279,837 |  |  | $ | (261,012) |  |  | $ | (426) |  |  | $ | 17,908 |
Balance - December 31, 2022 | 103,153 |  |  | $ | 10 |  |  | — |  |  | $ | — |  |  | $ | 275,562 |  |  | $ | (250,219) |  |  | $ | (472) |  |  | $ | 24,881 |
Exercise of stock options | 95 |  |  | — |  |  | — |  |  | — |  |  | 58 |  |  | — |  |  | — |  |  | 58 |
Release of restricted stock | 2,136 |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |
Issuance of restricted stock for earned bonus | 373 |  |  | — |  |  | — |  |  | — |  |  | 347 |  |  | — |  |  | — |  |  | 347 |
Issuance of common stock under the 2018 employee stock purchase plan | 93 |  |  | — |  |  | — |  |  | — |  |  | 47 |  |  | — |  |  | — |  |  | 47 |
Sales of common stock, net of issuance costs | 1,715 |  |  | — |  |  | — |  |  | — |  |  | 995 |  |  | — |  |  | — |  |  | 995 |
Stock-based compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | 2,828 |  |  | — |  |  | — |  |  | 2,828 |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 46 |  |  | 46 |
Treasury stock repurchase | — |  |  | — |  |  | (507) |  |  | (502) |  |  | — |  |  | — |  |  | — |  |  | (502)
Net loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (10,793) |  |  | — |  |  | (10,793)
Balance - June 30, 2023 | 107,565 |  |  | $ | 11 |  |  | (507) |  |  | $ | (502) |  |  | $ | 279,837 |  |  | $ | (261,012) |  |  | $ | (426) |  |  | $ | 17,908 |

4

Table of Contents

| Common Stock |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Other Comprehensive Loss |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |
Balance - March 31, 2022 | 97,251 |  |  | $ | 10 |  |  | $ | 266,606 |  |  | $ | (214,242) |  |  | $ | (384) |  |  | $ | 51,990 |
Release of restricted stock | 790 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Issuance of common stock under the 2018 employee stock purchase plan | 96 |  |  | — |  |  | 116 |  |  | — |  |  | — |  |  | 116 |
Stock-based compensation expense | — |  |  | — |  |  | 743 |  |  | — |  |  | — |  |  | 743 |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (85) |  |  | (85) |
Net income | — |  |  | — |  |  | — |  |  | (17,071) |  |  | — |  |  | (17,071)
Balance - June 30, 2022 | 98,137 |  |  | $ | 10 |  |  | $ | 267,465 |  |  | $ | (231,313) |  |  | $ | (469) |  |  | $ | 35,693 |
Balance - December 31, 2021 | 96,752 |  |  | $ | 10 |  |  | $ | 264,944 |  |  | $ | (199,325) |  |  | $ | (352) |  |  | $ | 65,277 |
Exercise of stock options, net of vesting of restricted shares | 23 |  |  | — |  |  | 16 |  |  | — |  |  | — |  |  | 16 |
Release of restricted stock | 882 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Issuance of common stock under the 2018 employee stock purchase plan | 96 |  |  | — |  |  | 116 |  |  | — |  |  | — |  |  | 116 |
Issuance of common stock in connection with acquisition of Lyte Technology, Inc. | 384 |  |  | — |  |  | 1,125 |  |  | — |  |  | — |  |  | 1,125 |
Stock-based compensation expense | — |  |  | — |  |  | 1,264 |  |  | — |  |  | — |  |  | 1,264 |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (117) |  |  | (117) |
Net loss | — |  |  | — |  |  | — |  |  | (31,988) |  |  | — |  |  | (31,988)
Balance - June 30, 2022 | 98,137 |  |  | $ | 10 |  |  | $ | 267,465 |  |  | $ | (231,313) |  |  | $ | (469) |  |  | $ | 35,693 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5

Table of Contents
Phunware, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

| Six Months Ended June 30,
| 2023 |  | 2022
Operating activities |  |  |
Net loss | $ | (10,793) |  |  | $ | (31,988) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
Amortization of debt discount and deferred financing costs | 697 |  |  | 259 |
Gain on change in fair value of warrant liability | (256) |  |  | (2,469) |
Gain on sale of digital assets | (5,310) |  |  | (194) |
Impairment of digital assets | 50 |  |  | 21,511 |
Impairment of goodwill | 1,203 |  |  | — |
Stock-based compensation | 2,824 |  |  | 1,270 |
Other adjustments | 1,180 |  |  | 478 |
Changes in operating assets and liabilities: |  |  |
Accounts receivable | 57 |  |  | 178 |
Inventory | 417 |  |  | (892) |
Prepaid expenses and other assets | 444 |  |  | (631) |
Accounts payable | 651 |  |  | 920 |
Accrued expenses | (997) |  |  | (386) |
Lease liability payments | (691) |  |  | (347) |
Deferred revenue | (2,036) |  |  | (2,698) |
Net cash used in operating activities | (12,560) |  |  | (14,989) |
Investing activities |  |  |
Proceeds received from sale of digital assets | 15,390 |  |  | — |
Purchase of digital assets | — |  |  | (923) |
Acquisition payment | — |  |  | (1,125) |
Capital expenditures | (9) |  |  | (158) |
Net cash provided by (used in) investing activities | 15,381 |  |  | (2,206) |
Financing activities |  |  |
Payments on borrowings | (4,270) |  |  | (3,132) |
Proceeds from sales of common stock, net of issuance costs | 995 |  |  | — |
Proceeds from exercise of options to purchase common stock | 58 |  |  | 16 |
Payment for stock repurchase | (502) |  |  | — |
Net cash used in financing activities | (3,719) |  |  | (3,116) |
Effect of exchange rate on cash | 48 |  |  | (121) |
Net decrease in cash | (850) |  |  | (20,432) |
Cash at the beginning of the period | 1,955 |  |  | 23,137 |
Cash at the end of the period | $ | 1,105 |  |  | $ | 2,705 |

6

Table of Contents

Supplemental disclosure of cash flow information: |  |  |
Interest paid | $ | 438 |  |  | $ | 408 |
Income taxes paid | $ | — |  |  | $ | — |
Supplemental disclosures of non-cash investing and financing activities: |  |  |
Right-of-use assets obtained in exchange for operating lease obligations | $ | — |  |  | $ | 1,508 |
Non-cash exchange of digital assets | $ | 557 |  |  | $ | 923 |
Issuance of common stock in connection with acquisition of Lyte Technology, Inc. | $ | — |  |  | $ | 1,125 |
Issuance of common stock under the 2018 Employee Stock Purchase Plan previously accrued | $ | 47 |  |  | $ | 116 |
Issuance of common stock for payment of bonuses previously accrued | $ | 347 |  |  | $ | — |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
7

Table of Contents
Phunware, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
(In thousands, except share and per share information)
(Unaudited)
1. The Company and Basis of Presentation
The Company
Phunware, Inc. and its subsidiaries (the “Company”, "we", "us", or "our") offers a fully integrated software platform that equips companies with the products, solutions and services necessary to engage, manage and monetize their anytime, anywhere users worldwide. Our location-based software-as-a-service platform provides the entire mobile lifecycle of applications and media in one login through one procurement relationship. Our technology is available in Software Development Kit ("SDK") form for organizations developing their own application, via customized development services and prepackaged solutions. Through our integrated mobile advertising platform of publishers and advertisers, we provide in-app application transactions for mobile audience building, user acquisition, application discovery, audience engagement and audience monetization. During 2021, we began to sell PhunToken to consumers, developers and brands. PhunToken is an innovative digital asset utilized within our token ecosystem to help drive engagement by unlocking features and capabilities of our platform. PhunToken is designed to reward consumers for their activity, such as watching branded videos, completing surveys and visiting points of interest. In October 2021, we acquired Lyte Technology, Inc. ("Lyte"), a provider of high-performance computer systems to individual consumers. Founded in 2009, we are a Delaware corporation headquartered in Austin, Texas.
Basis of Presentation
The condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) and include the Company’s accounts and those of its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
The balance sheet at December 31, 2022 was derived from our audited consolidated financial statements, but these interim condensed consolidated financial statements do not include all the annual disclosures required by U.S. GAAP. These interim condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended December 31, 2022, which are referenced herein. The accompanying interim condensed consolidated financial statements as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022, are unaudited. The unaudited interim condensed consolidated financial statements have been prepared on a basis consistent with the audited financial statements, pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary to fairly state our financial position as of June 30, 2023 and the results of operations for the three and six months ended June 30, 2023 and 2022, and cash flows for the six months ended June 30, 2023 and 2022. The results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim period.
Certain reclassifications have been made to the presentation for the six months ended June 30, 2022. Gain on sale of digital assets for the six months ended June 30, 2022, which was previously included in Other income, net in the condensed consolidated statement of operations and comprehensive loss and Other adjustments in the statement of cash flows has been reclassified to Gain on sale of digital assets in each respective financial statement.
Going Concern
Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern requires management to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s initial evaluation shall not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.
8

Table of Contents
We have a history of net losses since our inception. For the six months ended June 30, 2023, we incurred a net loss of $10,793, used $12,560 in cash for operations and have a working capital deficiency of $14,417. The foregoing conditions raise substantial doubt about our ability to meet our financial obligations as they become due.
In performing the next step of our going concern assessment, we are required to evaluate whether our plans to mitigate the conditions above alleviate the substantial doubt. Our assessment included the preparation of a detailed cash forecast that included projected cash inflows and outflows. We continue to focus on growing our revenues, and accordingly, we expect operating expenditures to exceed future revenue for the foreseeable future. In July 2023, we implemented a plan to decrease our cash burn by reducing headcount and other operating expenditures. Subsequent to June 30, 2023, we also raised additional funds in our at-the-market equity offering and entered into an amendment to our 2022 Promissory Note. Refer to Note 12 for further discussion. Our future plans may include additional reductions to operating expenses, additional sales of our common stock in our at-the-market offering, and issuing additional shares of common stock, preferred stock, warrants or units pursuant to an effective shelf registration statement.
Despite a history of successfully implementing similar plans, these sources of working capital are not currently assured, and consequently do not sufficiently mitigate the risks and uncertainties disclosed above. There can be no assurance that we will be able to obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted. We have therefore concluded there is substantial doubt about our ability to continue as a going concern through one year from the issuance of these financial statements.
The accompanying condensed consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
Nasdaq listing
On April 13, 2023, we received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”) because the bid price of the Company’s common stock on the Nasdaq Capital Market had closed below $1.00 per share for the previous 30 consecutive business days. The notice from Nasdaq states that, under Nasdaq Listing Rule 5810(c)(3)(A), we have been provided a period of 180 calendar days, or until October 10, 2023 (the “Compliance Date”), to regain compliance with the Bid Price Requirement. To regain compliance, the bid price of our common stock must close at $1.00 per share or more for a minimum of ten consecutive business days.
If we fail to regain compliance with the Bid Price Requirement prior to the Compliance Date, the Company may be eligible for an additional 180 calendar day compliance period, provided (i) it meets the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market (except for the Bid Price Requirement), and (ii) it provides written notice to Nasdaq of its intention to cure this deficiency during the second compliance period by effecting a reverse stock split, if necessary. In the event the Company does not regain compliance with the Bid Price Requirement prior to the expiration of the initial period, and if it appears to Nasdaq that the Company will not be able to cure the deficiency, or if we are not otherwise eligible, Nasdaq will provide us with written notification that its securities are subject to delisting from the Nasdaq Capital Market. At that time, we may appeal the delisting determination to a hearings panel.
2. Summary of Significant Accounting Policies
There have been no changes in significant accounting policies as described in our Annual Report on Form 10-K for the year ended December 31, 2022, except as set forth below.
Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). ASU 2016-13 introduces a model based on expected losses for most financial assets and certain other instruments. In addition, for available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than reductions in the amortized cost of the securities. We adopted this new standard effective January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on our condensed consolidated financial statements and disclosures.
9

Table of Contents
Recent Accounting Pronouncements Not Yet Adopted
In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40) (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. As of June 30, 2023, we did not have any debt with conversion features outstanding. On August 14, 2023, we entered into an amendment to our 2022 Promissory Note granting the noteholder certain limited conversion rights. See Note 12 for further discussion. The Company is currently evaluating the effect of this ASU on the amendment to its 2022 Promissory Note.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires us to make certain estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates and such differences could be material.
3. Supplemental Information
Risks and Uncertainties
Regulation governing blockchain technologies, cryptocurrencies, digital assets, digital asset exchanges, utility tokens, security tokens and offerings of digital assets is uncertain, and new regulations or policies may materially adversely affect the development and the value of our tokens and token ecosystem. Regulation of digital assets, like PhunCoin and PhunToken, cryptocurrencies, blockchain technologies and digital asset exchanges, is evolving and likely to continue to evolve. Regulation also varies significantly among international, federal, state and local jurisdictions and is subject to significant uncertainty. Various legislative and executive bodies in the United States and in other countries may in the future adopt laws, regulations, or guidance, or take other actions, which may severely impact the permissibility of tokens generally and the technology behind them or the means of transaction or in transferring them. Any such laws, regulations, guidance or other actions could adversely affect our ability to maintain PhunCoin and PhunToken, which could have a material adverse effect on our operations and financial condition. Failure by us to comply with any such laws and regulations, some of which may not exist yet or are subject to interpretation and may be subject to change, could also result in a material adverse effect on our operations and financial condition.
Concentrations of Credit Risk
Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash, trade accounts receivable and our digital asset holdings.
Although we limit our exposure to credit loss by depositing our cash with established financial institutions that management believes have good credit ratings and represent minimal risk of loss of principal, our deposits, at times, may exceed federally insured limits.
There is currently no clearing house for our digital assets, including our bitcoin holdings, nor is there a central or major depository for the custody of our digital assets. There is a risk that some or all of our digital asset holdings could be lost or stolen. There can be no assurance that the custodians will maintain adequate insurance or that such coverage will cover losses with respect to our digital asset holdings. Further, transactions denominated in digital assets are irrevocable. Stolen or incorrectly transferred digital assets may be irretrievable. As a result, any incorrectly executed transactions could adversely affect our financial condition. The aggregate cost basis (prior to impairment) of our digital asset holdings was $103 and $37,737 at June 30, 2023 and December 31, 2022, respectively.
10

Table of Contents
Collateral is not required for accounts receivable, and we believe the carrying value approximates fair value. The following table sets forth our concentration of accounts receivable, net of specific allowances for doubtful accounts.

| June 30, 2023 |  | December 31, 2022
Customer A | 16 | % |  | — | %
Customer B | 10 | % |  | — | %
Customer C | — | % |  | 23 | %

Inventory
Our inventory balance on the dates presented consisted of the following:

| June 30, 2023 |  | December 31, 2022
Raw materials | $ | 2,247 |  |  | $ | 2,968 |
Finished goods | 377 |  |  | 50 |
Other | 7 |  |  | 30 |
Inventory reserve | (463) |  |  | (268) |
Total inventory | $ | 2,168 |  |  | $ | 2,780 |

Goodwill Impairment
Goodwill arises from purchase business combinations and is measured as the excess of the cost of the business acquired over the sum of the acquisition-date fair values of tangible and identifiable intangible assets acquired, less any liabilities assumed. In accordance with ASC 350, Intangibles — Goodwill and Other, we do not amortize goodwill but rather assess its carrying value for indications of impairment annually, or more frequently if events or changes in circumstances indicate that the carrying amount may be impaired. We typically perform our annual goodwill impairment assessment as of October 1st of each year; however, as our stock has sustained a decline, we believe this, among other qualitative factors, including, but not limited to continued losses with our Lyte reporting unit, indicates the carrying amount of our goodwill may be impaired.
Our business is classified into two reporting units: Phunware and Lyte. We performed quantitative assessment on both our reporting units as of June 30, 2023, using a discounted cash flow model. Based on the analysis performed, we concluded that the carrying amount of our Lyte reporting unit exceeded its fair value resulting in a non-cash impairment charge of $1,203, which is recorded in Impairment of goodwill in the condensed consolidated statement of operations and comprehensive loss for the three and six months ended June 30, 2023.
The goodwill impairment analysis referenced above used the discounted cash flow model (income approach) utilizing Level 3 unobservable inputs. Significant assumptions in this analysis included, but were not limited to, future cash flow projections, the weighted average cost of capital, the terminal growth rate and the tax rate. Estimates of future cash flows are based on current regulatory and economic climates, recent operating results, and planned business strategies. These estimates could be negatively affected by changes in federal, state, or local regulations or economic downturns. Future cash flow estimates are, by their nature, subjective and actual results may differ materially from estimates. If the Company’s ongoing estimates of future cash flows are not met or if discount rates change, the Company may have to record additional impairment charges in future periods. We also used the Guideline Public Company Method (market approach). The significant assumptions used in this analysis include, but are not limited to, the derived multiples from comparable market transactions and other market data. The selection of comparable businesses is based on the markets in which the reporting unit operates giving consideration to risk profiles, size, geography, and diversity of products. We applied an overall probability-weighting to the income and market approaches to determine the concluded fair value of the reporting unit. We believe the current assumptions and estimates utilized in the income and market approaches are both reasonable and appropriate.
11

Table of Contents
Loss per Common Share
Basic loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted loss per common share is computed by giving effect to all potential shares of common stock, including those related to our outstanding warrants and stock equity plans, to the extent dilutive. For all periods presented, these shares were excluded from the calculation of diluted loss per share of common stock because their inclusion would have been anti-dilutive. As a result, diluted loss per common share is the same as basic loss per common share for all periods presented.
The following table sets forth common stock equivalents that have been excluded from the computation of dilutive weighted average shares outstanding as their inclusion would have been anti-dilutive:

| June 30, |  |
| 2023 |  | 2022 |  |  |  |
Warrants | 6,255,159 |  |  | 5,636,801 |  |  |  |  |
Options | 904,531 |  |  | 934,729 |  |  |  |  |
Restricted stock units | 4,843,881 |  |  | 2,621,346 |  |  |  |  |
Total | 12,003,571 |  |  | 9,192,876 |  |  |  |  |

Fair Value Measurements
We follow the guidance in ASC 820, Fair Value Measurement, to measure certain assets and liabilities on a recurring and nonrecurring basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. We use a fair value hierarchy, which distinguishes between assumptions based on market data (observable inputs) and an entity's own assumptions (unobservable inputs). The guidance requires fair value measurements be classified and disclosed in one of the following three categories:

• | Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.
• | Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.
• | Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

Determining which category an asset or liability falls within the hierarchy requires significant judgment. Our assets and liabilities measured at fair value on a recurring basis as of June 30, 2023 are set forth below:

| Level 1 |  | Level 2 |  | Level 3 |  | Total
Liabilities: |  |  |  |  |  |  |
Warrant liability | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Total | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |

Our financial instruments measured at fair value on a recurring basis as of December 31, 2022 are set forth below:

| Level 1 |  | Level 2 |  | Level 3 |  | Total
Liabilities: |  |  |  |  |  |  |
Warrant liability | $ | — |  |  | $ | 256 |  |  | $ | — |  |  | $ | 256 |
Total | $ | — |  |  | $ | 256 |  |  | $ | — |  |  | $ | 256 |

12

Table of Contents
The following table sets forth the assumptions used to calculate the fair values of the liability classified warrant issued in connection with our 2020 Convertible Notes as of the dates presented:

| June 30, 2023 |  | December 31, 2022
Strike price per share | $ | 1.42 |  |  | $ | 1.42 |
Closing price per share | $ | 0.54 |  |  | $ | 0.77 |
Term (years) | 0.04 |  | 0.53
Volatility | 47 | % |  | 102 | %
Risk-free rate | 5.24 | % |  | 4.70 | %
Dividend Yield | — |  | —

The carrying value of accounts receivable, prepaid expenses, other current assets, accounts payable and accrued expenses are considered to be representative of their respective fair values because of the short-term nature of those instruments.
13

Table of Contents
4. Revenue
Our platform revenue consists of SDK license subscriptions and application development services, as well as application transactions, which are comprised of in-app advertising and sales of our digital asset, PhunToken. Hardware revenue relates to the sale of high-performance personal computers. Refer to our revenue recognition policy under the subheading, Revenue Recognition, in Note 2, "Summary of Significant Accounting Policies," in our Annual Report on Form 10-K filed with the SEC on March 31, 2023.
Disaggregation of Revenue
The following table sets forth our net revenues by category:

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Platform revenue | $ | 1,295 |  |  | $ | 1,628 |  |  | $ | 2,640 |  |  | $ | 4,120 |
Hardware revenue | 2,192 |  |  | 3,857 |  |  | 5,594 |  |  | 8,143 |
Net revenues | $ | 3,487 |  |  | $ | 5,485 |  |  | $ | 8,234 |  |  | $ | 12,263 |

We generate revenue in domestic and foreign regions and attribute net revenue to individual countries based on the location of the contracting entity. We derived 100% of our net revenues from within the United States for the three and six months ended June 30, 2023. During the three and six months ended June 30, 2022, we derived 98% and 97% of our net revenues from the United States, respectively.
Deferred Revenue
Our deferred revenue balance consisted of the following:

| June 30, 2023 |  | December 31, 2022
Current deferred revenue |  |  |
Platform revenue | $ | 1,068 |  |  | $ | 1,531 |
Hardware revenue | 24 |  |  | 1,373 |
Total current deferred revenue | $ | 1,092 |  |  | $ | 2,904 |
Non-current deferred revenue |  |  |
Platform revenue | $ | 1,050 |  |  | $ | 1,274 |
Total non-current deferred revenue | $ | 1,050 |  |  | $ | 1,274 |
Total deferred revenue | $ | 2,142 |  |  | $ | 4,178 |

Deferred revenue consists of customer billings or payments received in advance of the recognition of revenue under the arrangements with customers. We recognize deferred revenue as revenue only when revenue recognition criteria are met. During the six months ended June 30, 2023, we recognized revenue of $2,741 that was included in our deferred revenue balance as of December 31, 2022.
Remaining Performance Obligations
Remaining performance obligations were $5,238 as of June 30, 2023, of which we expect to recognize approximately 33% as revenue over the next 12 months and the remainder thereafter.
PhunToken
In 2021, we announced the commencement of the selling of PhunToken. PhunToken is our innovative digital asset intended to be utilized within our token ecosystem, once developed, to help drive engagement by unlocking features and capabilities of our platform. We did not sell any PhunToken during the six months ended June 30, 2023. During the six months
14

Table of Contents
ended June 30, 2022, we sold 186.8 million PhunToken for an aggregate of $1,533, for which we received both cash and digital assets from customers. Sales of PhunToken are recorded within platform revenue in the table above.
As of June 30, 2023 and December 31, 2022, total issued PhunToken were 377.2 million. Total supply of PhunToken is capped at 10 billion.
5. Digital Assets
Payments by customers in and purchases by us of digital assets were primarily of bitcoin and ethereum. We currently account for all digital assets held as a result of these transactions as indefinite-lived intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. We have ownership of and control over our digital assets and we may use third-party custodial services or self-custody solutions to secure them. The digital assets are initially recorded at cost and are subsequently remeasured, net of any impairment losses incurred since acquisition.
We determine the fair value of our digital assets on a nonrecurring basis in accordance with ASC 820, Fair Value Measurement, based on quoted prices on the active exchange(s) that we have determined is the principal market for bitcoin, ethereum and other digital asset holdings (Level 1 inputs). We perform an analysis each quarter to identify whether events or changes in circumstances, principally decreases in the quoted prices on active exchanges, indicate that it is more likely than not that our digital assets are impaired. In determining if an impairment has occurred, we consider the lowest intraday market price quoted on an active exchange since acquiring the respective digital asset. If the then current carrying value of a digital asset exceeds the fair value, an impairment loss has occurred with respect to those digital assets in the amount equal to the difference between their carrying values and the fair value. The fair value of our digital asset holdings at June 30, 2023 is $84.
The impaired digital assets are written down to their fair value at the time of impairment and this new cost basis will not be adjusted upward for any subsequent increase in fair value. Gains are not recorded until realized upon sale, at which point they are presented net of any impairment losses for the same digital assets held. In determining the gain or loss to be recognized upon sale, we calculate the difference between the sales price and carrying value of the digital assets sold immediately prior to sale. Impairment losses and gains or losses on sales are recognized within other income (expense) in our condensed consolidated statements of operations and comprehensive loss. Impairment loss was $0 and $12,158 for the three months ended June 30, 2023 and 2022, respectively. We recognized $50 and $21,511 of impairment losses during the six months ended June 30, 2023 and 2022, respectively.
The following table sets forth our digital asset holdings as of June 30, 2023:

Asset | Gross Carrying Amount |  | Accumulated Digital Asset Impairment |  | Digital Asset Carrying Value |  |  |  |
Bitcoin | $ | 16 |  |  | $ | (3) |  |  | $ | 13 |  |  |  |  |
Ether | 80 |  | (28) |  | $ | 52 |  |  |  |  |
Other | 7 |  | (1) |  | $ | 6 |  |  |  |  |
Total | $ | 103 |  |  | $ | (32) |  |  | $ | 71 |  |  |  |  |

The following table sets forth our digital asset holdings as of December 31, 2022:

Asset | Gross Carrying Amount |  | Accumulated Digital Asset Impairment |  | Digital Asset Carrying Value |  |  |  |
Bitcoin | $ | 34,994 |  |  | $ | (25,534) |  |  | $ | 9,460 |  |  |  |  |
Ether | 1,506 |  |  | (1,156) |  |  | 350 |  |  |  |  |
Other | 1,237 |  |  | (910) |  |  | 327 |  |  |  |  |
Total | $ | 37,737 |  |  | $ | (27,600) |  |  | $ | 10,137 |  |  |  |  |

15

Table of Contents
Gross carrying amount and accumulated digital asset impairment noted above represent carrying amount and impairment, respectively, on the remaining cost lots as of the respective dates. Changes in our digital asset holdings for six months ended June 30, 2023 were as follows:

| Bitcoin |  | Ethereum |  | Other |  | Total |  |  |  |
Net balance as of December 31, 2022 | $ | 9,460 |  |  | $ | 350 |  |  | $ | 327 |  |  | $ | 10,137 |  |  |  |  |
Received from customers, net of expenses | — |  |  | (1) |  |  | 65 |  |  | 64 |  |  |  |  |
Exchanges of digital assets | — |  |  | 557 |  |  | (557) |  |  | — |  |  |  |  |
Disposal proceeds | (14,154) |  |  | (1,236) |  |  | — |  |  | (15,390) |  |  |  |  |
Gain on sale of digital assets | 4,707 |  |  | 382 |  |  | 221 |  |  | 5,310 |  |  |  |  |
Impairment expense | — |  |  | — |  |  | (50) |  |  | (50) |  |  |  |  |
Net balance as of June 30, 2023 | $ | 13 |  |  | $ | 52 |  |  | $ | 6 |  |  | $ | 71 |  |  |  |  |

16

Table of Contents
6. Debt
2022 Promissory Note
On July 6, 2022, we entered into a note purchase agreement and completed the sale of an unsecured promissory note (the "2022 Promissory Note") with an original principal amount of $12,809 in a private placement. The 2022 Promissory Note was sold with an original issue discount of $492 and we paid at closing issuance costs totaling $522. After deducting all transaction fees paid by us at closing, net cash proceeds to the Company at closing were $11,795. No interest was to accrue on the 2022 Promissory Note. Beginning on November 1, 2022, our monthly amortization payment was approximately $1,566, until the original maturity date of July 1, 2023. We had the right to defer any monthly payment by one month up to twelve times so long as certain conditions, as defined in the 2022 Promissory Note, are satisfied. In the event we exercise the deferral right for any given month: (i) the outstanding balance will automatically increase by 1.85%; (ii) we will not be obligated to make the monthly payment for such month; and (iii) the maturity date will be extended for one month. We may prepay any or all outstanding balance of the 2022 Promissory Note earlier than it is due by paying the noteholder 110% of the portion of the outstanding balance we elect to prepay. The prepayment premium also applies to the monthly amortization payments.
On March 15, 2023, we elected to defer monthly payment obligations for April, May, June and July 2023, as permitted, at the time, by the 2022 Promissory Note. In connection therewith, we entered into a waiver agreement with the holder waiving the Payment Deferral Conditions, as defined in the 2022 Promissory Note. For agreeing to waive the Payment Deferral Conditions, we agreed to compensate the noteholder an amount equal to 5% of the outstanding balance immediately before entering into the waiver agreement. As a result of our election to defer the four (4) monthly payments, the outstanding balance of the 2022 Promissory Note was increased by 1.85% on the first day of each month beginning on April 1, 2023 and concluding on July 1, 2023. The waiver fee and the additional principal was to be paid in connection with our monthly installment payments once the deferral period concluded. Beginning on August 1, 2023 and on the same day of each month thereafter, we were required to pay to the noteholder the new monthly amortization payment in the amount of $1,769. We evaluated the modification in accordance with the guidance as in ASC 470 - Debt, and we concluded that the modification was not an extinguishment of the original debt; therefore, no gain or loss was recognized upon modification. As a result of entering into the waiver agreement, the effective interest rate of the 2022 Promissory Note as of June 30, 2023 was approximately 34.98%. On August 14, 2023, we entered into an amendment to the 2022 Promissory Note with the noteholder. See Note 12 for further discussion.
The 2022 Promissory Note had a principal balance of $6,432 and $9,962 and debt discount of $338 and $295 at June 30, 2023 and December 31, 2022, respectively.
Other Debt Obligations
Other than the 2022 Promissory Note referenced above, there have been no material changes to the terms and conditions of our other debt obligations since the filing of our Annual Report on Form 10-K. See Note 8, "Debt", in our Annual Report on Form 10-K filed with the SEC on March 31, 2022.
Interest Expense
Interest expense amounted to $553 and $273 for the three months ended June 30, 2023 and 2022, respectively. Interest expense was $1,090 and $654 for the six months ended June 30, 2023 and 2022, respectively.
17

Table of Contents
7. Leases
Further information regarding our other office leases and accounting thereof are located in Note 2, "Summary of Significant Accounting Policies," and Note 9, "Leases," in our Annual Report on Form 10-K filed with the SEC on March 31, 2023.
We recognize lease expense on a straight-line basis over the lease term with variable lease expense recognized in the period in which the costs are incurred. The components of lease expense are included in general and administrative expense in our condensed consolidated statement of operations and comprehensive loss. Lease expense for the three months ended June 30, 2023 and 2022 was $324 and $236, respectively. Lease expense for the six months ended June 30, 2023 and 2022 was $649 and $440, respectively. The weighted-average remaining lease term for operating leases as of June 30, 2023 was 3.6 years.
Future minimum lease obligations are set forth below:

Future minimum lease obligations years ending December 31, |  | Lease Obligations
2023 (Remainder) |  | $ | 605 |
2024 |  | 1,305 |
2025 |  | 929 |
2026 |  | 744 |
2027 |  | 508 |
Thereafter |  | — |
|  | $ | 4,091 |
Less: Portion representing interest |  | (539) |
|  | $ | 3,552 |

8. Commitments and Contingencies
Litigation
Except as set forth below, there have been no material changes to the disclosures related to our litigation matters since the filing of our Annual Report on Form 10-K. See Note 10, "Commitments and Contingencies," in our Annual Report on Form 10-K filed with the SEC on March 31, 2023 for further information.
On February 18, 2022, certain stockholders filed a lawsuit against Phunware and its individual officers and directors. The case, captioned Wild Basin Investments, LLC, et al. v. Phunware, Inc., et al., was filed in the Court of Chancery of the state of Delaware (Cause No. 2022-0168-LWW). Plaintiffs alleged that they invested in various early rounds of financing while the Company was private and that Phunware should not have subjected their shares to a 180-day “lock up” period. Plaintiffs also allege that Phunware’s stock price dropped significantly during the lock up period and seek damages, costs and professional fees. We filed a motion to dismiss the complaint on May 27, 2022 and on July 15, 2022, Plaintiffs filed their answering brief in opposition to the motion to dismiss and a partial motion for summary judgement. All briefing and oral argument on the motion to dismiss and motion for partial summary judgement is complete. Both parties argued their positions before the Court of Chancery during a hearing on April 4, 2023. On June 16, 2023, the Court ruled on the motions without filing a written opinion. From the bench, Vice Chancellor Cook granted Phunware’s motion to dismiss on the Texas law-based claims and denied both the motion to dismiss and partial motion for summary judgment on the Delaware law claims. The parties engaged in mediation in July 2023 and are scheduled for further mediation in late August 2023. We intend to vigorously defend against this lawsuit and any appeals. We have not recorded a liability related to this matter because any potential loss is not currently probable or reasonably estimable. Additionally, we cannot presently estimate the range of loss, if any, that may result from the matter. It is possible that the ultimate resolution of the foregoing matter, or other similar matters, if resolved in a manner unfavorable to us, may be materially adverse to our business, financial condition, results of operations or liquidity.
From time to time, we are and may become involved in various legal proceedings in the ordinary course of business. The outcomes of our legal proceedings are inherently unpredictable, subject to significant uncertainties, and could be material to our operating results and cash flows for a particular reporting period. In addition, for the matters disclosed above that do not
18

Table of Contents
include an estimate of the amount of loss or range of losses, such an estimate is not possible, and we may be unable to estimate the possible loss or range of losses that could potentially result from the application of non-monetary remedies.
19

Table of Contents
9. Stockholders’ Equity
Common Stock
Total common stock authorized to be issued as of June 30, 2023 was 1,000,000,000 shares, with a par value of $0.0001 per share. As of June 30, 2023 and December 31, 2022, there were 107,058,624 and 103,153,337 shares of our common stock outstanding, respectfully.
On January 31, 2022, we entered into an At Market Issuance Sales Agreement with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which we may offer and sell, from time to time, shares of our common stock, par value $0.0001 per share, for aggregate gross proceeds of up to $100,000, through or to Wainwright, as agent or principal. We are not obligated to sell shares of our common stock under the sales agreement with Wainwright. Sales of shares of our common stock sold under the sales agreement are made pursuant to an effective shelf registration statement on Form S-3 in the amount of $200,000 filed with the SEC on February 1, 2022. During the six months ended June 30, 2023, we sold 1,715,136 shares of our common stock for aggregate net cash proceeds of $995. Transaction costs were $32. As of June 30, 2023, $94.4 million of shares of our common stock remains issuable pursuant to the sales agreement with Wainwright.
Stock Repurchase Plan
On January 5, 2023, our board of directors authorized and approved a stock repurchase program for the repurchase of outstanding shares of our common stock with an aggregate value of up to $5,000. The authorization permits us to repurchase shares of our common stock from time-to-time through open market repurchases at prevailing market prices, in accordance with federal securities laws. The stock repurchase plan is expected to be completed over the next twelve (12) months and may be amended or terminated at any time, in the sole discretion of the board. The exact means, number and timing of stock repurchases depend on market conditions, applicable legal requirements and other factors, and have been funded through the liquidation of our bitcoin holdings. During the six months ended June 30, 2023, we repurchased 506,500 shares of our common stock at an aggregate repurchase price of $502.
Warrants
We have various warrants outstanding. A summary of our outstanding warrants is set forth below:

|  | June 30, 2023 |  | December 31, 2022 |  |
Warrant Type |  | Cash Exercise Price per share |  | Number of warrants |  | Cash Exercise Price per share |  | Number of warrants |  |
2020 Convertible Note warrant |  | $ | 1.42 |  |  | 2,811,315 |  |  | $ | 1.42 |  |  | 2,811,315 |  |  |
Common stock warrants (Series F) |  | $ | 9.22 |  |  | — |  |  | $ | 9.22 |  |  | 377,402 |  |  |
Public warrants (PHUNW) |  | $ | 11.50 |  |  | 1,761,291 |  |  | $ | 11.50 |  |  | 1,761,291 |  |  |
Private placement warrants |  | $ | 11.50 |  |  | 1,658,381 |  |  | $ | 11.50 |  |  | 1,658,381 |  |  |
Unit purchase option warrants |  | $ | 11.50 |  |  | 24,172 |  |  | $ | 11.50 |  |  | 24,172 |  |  |
Total |  |  |  | 6,255,159 |  |  |  |  | 6,632,561 |  |  |

Except as set forth below, there have been no material changes to the terms of our outstanding warrants. Additional information about our various warrants outstanding is included under the subheading, "Warrants", in Note 12, "Stockholders' Equity," in our Annual Report on Form 10-K filed with the SEC on March 31, 2023.
2020 Convertible Note Warrant
In connection with the issuance of the 2020 Convertible Notes, in 2020, we issued a warrant exercisable for three (3) years for the purchase, initially, of up to an aggregate of 2,160,000 shares of the Company's common stock at an initial exercise price of $4.00 per share. The number of shares and exercise price are each subject to adjustment provided under the warrant. As a result of our underwritten public offering in February 2021, the exercise price of each share decreased to $2.25 per share, and the number of shares for which the warrant is exercisable increased to 3,840,000 shares. Furthermore, in October 2021, we issued shares to the seller of Lyte as purchase consideration at a price of $1.4246 per share, and as a result, the exercise price of
20

Table of Contents
the warrant adjusted accordingly and the number of shares exercisable thereunder increased to 2,811,315. The holder also partially exercised the warrant in 2021.
If, at the time of exercise of the warrant, there is no effective registration statement registering, or no current prospectus available for, the issuance of the shares, then the warrant may also be exercised, in whole or in part, by means of a “cashless exercise.” The registration statement registering 2,160,000 shares of our common stock issuable pursuant to the terms of the warrant was declared effective by the SEC on October 27, 2020. In April 2022, we filed a registration statement, as amended, registering 250% of the additional warrant shares as result of the adjustment noted above. The registration statement was declared effective by the SEC on May 2, 2022. The warrant may not be exercised if, after giving effect to the exercise, the investor would beneficially own amounts in excess of those permissible under the terms of the warrant. The warrant expired July 15, 2023.
10. Stock-Based Compensation
Stock-Based Compensation
Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:

| Three Months Ended June 30, |  | Six Months Ended June 30,
Stock-based compensation | 2023 |  | 2022 |  | 2023 |  | 2022
Cost of revenues | $ | 111 |  |  | $ | 49 |  |  | $ | 364 |  |  | $ | 95 |
Sales and marketing | 35 |  |  | 27 |  |  | 132 |  |  | 45 |
General and administrative | 1,260 |  |  | 595 |  |  | 2,119 |  |  | 1,067 |
Research and development | 56 |  |  | 35 |  |  | 209 |  |  | 63 |
Total stock-based compensation | $ | 1,462 |  |  | $ | 706 |  |  | $ | 2,824 |  |  | $ | 1,270 |

As of June 30, 2023, there was approximately $324, $1,068, $3,098, $167 and $0.2 of total unrecognized compensation cost related to the 2023 Inducement Plan, the 2022 Inducement Plan, the 2018 Equity Incentive Plan (the "2018 Plan"), the 2018 Employee Stock Purchase Plan (the "2018 ESPP") and the 2009 Equity Incentive Plan (the "2009 Plan"), respectively. These unrecognized compensation costs are expected to be recognized over an estimated weighted-average period of approximately 2.9 years, 2.5 years, 1.7 years, 1.9 years and 0.4 years for the 2023 Inducement Plan, 2022 Inducement Plan, 2018 Plan, the 2018 ESPP and 2009 Plan, respectively.
Except as set forth below, there have been no material changes to the terms of the 2018 Plan, the 2018 ESPP and the 2009 Plan since the filing of our Annual Report on Form 10-K. Refer to Note 13, "Stock-Based Compensation," in our Annual Report on Form 10-K filed with the SEC on March 31, 2023 for more information on our various equity incentive plans.
2023 Inducement Plan
Our board of directors adopted the Phunware, Inc. 2023 Inducement Plan (the "2023 Inducement Plan") in June 2023. As permitted by Nasdaq Stock Market rules, our stockholders were not required to approve the 2023 Inducement Plan. The plan provides of up to 600,000 shares of our common stock under awards granted to newly hired employees. An "award" is any right to receive common stock of the Company consisting of nonstatutory stock options, stock appreciation rights, restricted stock awards or restricted stock units.
On June 30, 2023, we made an inducement grant to a newly hired officer of the Company of 600,000 restricted stock units under the 2023 Inducement Plan with a grant date fair value of $0.54 per share. One-third of the restricted stock units will vest on June 3, 2024 and the remainder will vest in equal installments over two annual periods beginning on June 2, 2025 and concluding on June 1, 2026, subject to the employee's continued service on such vesting date. Shares will be delivered electronically to the holder shortly after vest date.
2022 Inducement Plan
Our board of directors adopted the Phunware, Inc. 2022 Inducement Plan (the "2022 Inducement Plan") in January 2023. As permitted by Nasdaq Stock Market rules, our stockholders were not required to approve the 2022 Inducement Plan.
21

Table of Contents
The plan provides of up to 1,470,588 shares of our common stock under awards granted to newly hired employees. An "award" is any right to receive common stock of the Company consisting of nonstatutory stock options, stock appreciation rights, restricted stock awards or restricted stock units.
In January 2023, we made an inducement grant to a newly hired officer of the Company of 1,470,588 restricted stock units under the 2022 Inducement Plan with a grant date fair value of $0.87 per share. One-third, or 490,196, of the restricted stock units will vest on December 28, 2023 and the remainder will vest in equal installments over eight quarterly periods beginning on March 31, 2024 with the final vesting date occurring on December 28, 2025, subject to the employee's continued service on such vesting date. Shares will be delivered electronically to the holder shortly after vest date.
2018 Equity Incentive Plan
Shares of common stock reserved for issuance under the 2018 Plan also include any shares of common stock subject to stock options, restricted stock units or similar awards granted under the 2009 Plan, that, on or after the adoption of the 2018 Plan, expire or otherwise terminate without having been exercised in full and shares of common stock issued pursuant to awards granted under the 2009 Plan that are forfeited to or repurchased by us. As of June 30, 2023, the maximum number of shares of common stock that may be added to the 2018 Plan pursuant to the foregoing is 779,531. Not including the maximum number of shares from the 2009 Plan that may be added to the 2018 Plan, the 2018 Plan had 7,178,608 and 4,382,662 shares of common stock reserved for future issuances as of June 30, 2023 and December 31, 2022, respectively.
Restricted Stock Units
A summary of our restricted stock unit activity under the 2018 Plan for the six months ended June 30, 2023 is set forth below:

| Shares |  | Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2022 | 2,957,995 |  |  | $ | 1.75 |
Granted | 2,616,704 |  |  | 0.88 |
Released | (2,508,922) |  |  | 1.20 |
Forfeited | (292,484) |  |  | 1.51 |
Outstanding as of June 30, 2023 | 2,773,293 |  |  | $ | 1.25 |

During the first quarter of 2023, we granted 1,921,000 restricted stock unit awards to team members with an average grant date fair value of $0.92 per share. The vesting provisions were generally such that one-third of the awards vested immediately with the remaining vesting at various dates through November 2024. We also granted 372,704 restricted stock unit awards to members of our team in lieu of cash bonus earned during 2022 with a grant date fair value of $0.93. These awards vested immediately.
During the second quarter of 2023, we granted 323,000 restricted stock unit awards to team members with an average grant date fair value of $0.60 per share. The vesting of these awards occurs at various dates through May 2027.
22

Table of Contents
Stock Options
A summary of our stock option activity under the 2018 Plan and related information is as follows:

| Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (years) |  | Aggregate Intrinsic Value
Outstanding as of December 31, 2022 | 87,500 |  |  | $ | 1.43 |  |  | 5.6 |  | $ | — |
Granted | 75,000 |  |  | 0.76 |  |  |  |  |
Exercised | — |  |  | — |  |  |  |  |
Forfeited | (37,500) |  |  | 1.08 |  |  |  |  |
Outstanding as of June 30, 2023 | 125,000 |  |  | $ | 1.14 |  |  | 5.4 |  | $ | — |
Exercisable as of June 30, 2023 | 106,250 |  |  | $ | 1.20 |  |  | 5.4 |  | $ | — |

2018 Employee Stock Purchase Plan
We use a Black-Scholes option pricing model to determine the fair value of shares to be purchased under the 2018 ESPP. Stock-based compensation expense related to our 2018 ESPP for the six months ended June 30, 2023 was not significant. There were 1,528,745 and 802,893 shares of common stock available for sale and reserved for issuance as of June 30, 2023 and December 31, 2022, respectively.
2009 Equity Incentive Plan
A summary of our option activity under the 2009 Plan and related information is as follows:

| Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (years) |  | Aggregate Intrinsic Value
Outstanding as of December 31, 2022 | 874,279 |  |  | $ | 0.80 |  |  | 4.2 |  | $ | 130 |
Granted | — |  |  | — |  |  |  |  |
Exercised | (94,748) |  |  | 0.61 |  |  |  |  |
Forfeited | — |  |  | — |  |  |  |  |
Outstanding as of June 30, 2023 | 779,531 |  |  | $ | 0.83 |  |  | 4.1 |  | $ | 1 |
Exercisable as of June 30, 2023 | 779,339 |  |  | $ | 0.83 |  |  | 4.1 |  | $ | 1 |

For the three months ended June 30, 2023, the aggregate intrinsic value of options exercised was $16 and the total fair value of options vested was not significant.
23

Table of Contents
11. Segment and Geographic Information
Our chief operating decision maker is our Chief Executive Officer ("CEO"). Our CEO reviews operating segment information for the purposes of allocating resources and evaluating financial performance. We have determined that the Company operates in a two reporting segments: Phunware and Lyte.
Selected information for the Company's operating segments and a reconciliation to the condensed consolidated financial statement amounts are as follows:

| Three Months Ended June 30, 2023 |  | Three Months Ended June 30, 2022
| Phunware |  | Lyte |  | Consolidated |  | Phunware |  | Lyte |  | Consolidated
Net revenues | $ | 1,295 |  |  | $ | 2,192 |  |  | $ | 3,487 |  |  | $ | 1,628 |  |  | $ | 3,857 |  |  | $ | 5,485 |
Loss before taxes | $ | (4,349) |  |  | $ | (2,175) |  |  | $ | (6,524) |  |  | $ | (16,708) |  |  | $ | (363) |  |  | $ | (17,071) |

| Six Months Ended June 30, 2023 |  | Six Months Ended June 30, 2022
| Phunware |  | Lyte |  | Consolidated |  | Phunware |  | Lyte |  | Consolidated
Net revenues | $ | 2,640 |  |  | $ | 5,594 |  |  | $ | 8,234 |  |  | $ | 4,120 |  |  | $ | 8,143 |  |  | $ | 12,263 |
Loss before taxes | $ | (7,950) |  |  | $ | (2,843) |  |  | $ | (10,793) |  | $ | (10,793) |  | $ | (31,067) |  |  | $ | (921) |  |  | $ | (31,988) |

| June 30, 2023 |  | December 31, 2022
| Phunware |  | Lyte |  | Consolidated |  | Phunware |  | Lyte |  | Consolidated
Goodwill | $ | 25,811 |  |  | $ | 4,145 |  |  | $ | 29,956 |  |  | $ | 25,765 |  |  | $ | 5,348 |  |  | $ | 31,113 |
Total assets | $ | 29,633 |  |  | $ | 11,157 |  |  | $ | 40,790 |  |  | $ | 42,349 |  |  | $ | 12,486 |  |  | $ | 54,835 |

Identifiable long-lived assets attributed to the United States and international geographies are based upon the country in which the asset is located or owned. As of June 30, 2023 and December 31, 2022, all of our identifiable long-lived assets were in the United States.
12. Subsequent Events
From July 1, 2023 through August 14, 2023, we sold an additional 13,086,060 shares of our common stock pursuant to the terms of our At Market Issuance Sales Agreement with Wainwright for aggregate net cash proceeds of $5,489. Transaction costs were not significant.
From July 1, 2023 through August 14, 2023, vested restricted stock units covering 210,900 shares of our common stock were released to team members and service providers that related to grants previously awarded to those individuals.
On August 14, 2023, we entered into an amendment to the 2022 Promissory Note with the noteholder. The amendment extends the maturity date to June 1, 2024 and provides that effective August 1, 2023, we are required to make monthly amortization payments of at least $800 commencing on August 31, 2023 until the 2022 Promissory Note is paid-in-full. Furthermore, the amendment removed the required payment of $1,769 that was due on August 1, 2023. We also granted the holder certain limited conversion rights, subject to advance payment and volume conditions. Conversions into shares of our common stock made pursuant to the limited conversion rights will be calculated on a conversion price equal to 90% of the lower of (i) the closing trading price of our common stock on the trading day immediately preceding the date for such conversion or (ii) the average closing trading price of our common stock for the five trading days immediately preceding the date for such conversion. If the holder elects to convert pursuant to the limited conversion option, such conversions will reduce the current month’s monthly amortization payment. Any conversions in any given month in excess of the $800 monthly payment will be applied to reduce the following month's required monthly amortization payment. In connection with the amendment, we agreed to pay an extension fee equal to approximately $708, which is 10% of the outstanding principal balance of the 2022 Promissory Note. The amendment also provides that the outstanding balance shall accrue interest at a rate of 8% beginning on August 1, 2023, and payment deferrals are no longer permitted under the 2022 Promissory Note.
24

Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this section to “we,” “us,” "our," or “the Company” refer to Phunware, Inc. References to “management” or “management team” refer to our officers and directors.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes thereto presented in “Part I – Item 1. Financial Statements.” As discussed in the section titled "Special Note Regarding Forward-Looking Statements," the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including, but not limited to, those discussed in the section titled “Risk Factors” and elsewhere in this Report.
Certain figures, such as interest rates and other percentages, included in this section have been rounded for ease of presentation. Percentage figures included in this section have not in all cases been calculated on the basis of such rounded figures but on the basis of such amounts prior to rounding. For this reason, percentage amounts in this section may vary slightly from those obtained by performing the same calculations using the figures in our condensed consolidated financial statements or in the associated text. Certain other amounts that appear in this section may similarly not sum due to rounding.
Overview
Phunware, Inc. offers a fully integrated software platform that equips companies with the products, solutions and services necessary to engage, manage and monetize their mobile application portfolios globally at scale. Our location-based software-as-a-service platform provides the entire mobile lifecycle of applications, media and data in one login through one procurement relationship. Our offerings include:

| •Enterprise mobile software development kits (SDKs) including content management, location-based services, marketing automation, business intelligence and analytics, alerts, notifications and messaging, audience engagement and audience monetization;
| •Integration of our SDK licenses into existing applications maintained by our customers, as well as custom application development and support services;
| •Cloud-based vertical solutions, which are off-the-shelf, iOS- and Android-based mobile application portfolios, solutions and services that address: the patient experience for healthcare, the shopper experience for retail, the fan experience for sports, the traveler experience for aviation, the luxury resident experience for real estate, the luxury guest experience for hospitality, the student experience for education and the generic user experience for all other verticals and applications; and
| •Application transactions for mobile audience building, user acquisition, application discovery, audience engagement and monetization, including our engagement-driven digital asset PhunToken.

We also offer and sell pre-packaged and custom high-end personal computer systems for gaming, streaming and cryptocurrency mining enthusiasts.
We intend to continue investing for long-term growth. We have invested and expect to continue investing in the expansion of our ability to market, sell and provide our current and future products and services to customers globally. We also expect to continue investing in the development and improvement of new and existing products and services to address customers' needs. We currently do not expect to be profitable in the near future.
25

Table of Contents
Key Business Metrics
Our management regularly monitors certain financial measures to track the progress of our business against internal goals and targets. We believe that the most important of these measures include backlog and deferred revenue.
Backlog and Deferred Revenue. Backlog represents future amounts to be invoiced under our current agreements. At any point in the contract term, there can be amounts that we have not yet been contractually able to invoice. Until such time as these amounts are invoiced, they are not recorded in revenue, deferred revenue, accounts receivable or elsewhere in our condensed consolidated financial statements, and are considered by us to be backlog. We expect backlog to fluctuate up or down from period to period for several reasons, including the timing and duration of customer contracts, varying billing cycles and the timing and duration of customer renewals. We reasonably expect approximately 43% of our backlog as of June 30, 2023 will be invoiced during the subsequent 12-month period, primarily due to the fact that our contracts are typically one to three years in length.
In addition, our deferred revenue consists of amounts that have been invoiced but have not yet been recognized as revenues as of the end of the reporting period. Together, the sum of deferred revenue and backlog represents the total billed and unbilled contract value yet to be recognized in revenues and provides visibility into future revenue streams.
The following table sets forth our backlog and deferred revenue:

| June 30, 2023 |  | December 31, 2022
(in thousands) |
Backlog | $ | 3,096 |  |  | $ | 3,824 |
Deferred revenue | 2,142 |  |  | 4,178 |
Total backlog and deferred revenue | $ | 5,238 |  |  | $ | 8,002 |

Non-GAAP Financial Measures
Adjusted Gross Profit, Adjusted Gross Margin and Adjusted EBITDA
We report our financial results in accordance with accounting principles generally accepted in the United States of America ("GAAP"). We also use certain non-GAAP financial measures that fall within the meaning of Securities and Exchange Commission Regulation G and Regulation S-K Item 10(e), which may provide users of the financial information with additional meaningful comparison to prior period results. Our non-GAAP financial measures include adjusted gross profit, adjusted gross margin and adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") (our "non-GAAP financial measures"). Management uses these measures (i) to compare operating performance on a consistent basis, (ii) to calculate incentive compensation for our employees, (iii) for planning purposes including the preparation of our internal annual operating budget and (iv) to evaluate the performance and effectiveness of operational strategies.
Our non-GAAP financial measures should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. They are not measurements of our financial performance under GAAP and should not be considered as alternatives to revenue or net loss, as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. Our non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of our operating results as reported under GAAP. Some of these limitations include:

| •Non-cash compensation is and will remain a key element of our overall long-term incentive compensation package, although we exclude it as an expense when evaluating our ongoing operating performance for a particular period;
| •Our non-GAAP financial measures do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of ongoing operations; and
| •Other companies in our industry may calculate our non-GAAP financial measures differently than we do, limiting their usefulness as comparative measures.

26

Table of Contents
We compensate for these limitations to our non-GAAP financial measures by relying primarily on our GAAP results and using our non-GAAP financial measures only for supplemental purposes. Our non-GAAP financial measures include adjustments for items that may not occur in future periods. However, we believe these adjustments are appropriate because the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our business and complicate comparisons of our internal operating results and operating results of other peer companies over time. For example, it is useful to exclude non-cash, stock-based compensation expenses because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and these expenses can vary significantly across periods due to timing of new stock-based awards. We may also exclude certain discrete, unusual, one-time, or non-cash costs in order to facilitate a more useful period-over-period comparison of our financial performance. Each of the normal recurring adjustments and other adjustments described in this paragraph help management with a measure of our operating performance over time by removing items that are not related to day-to-day operations or are non-cash expenses.
The following table sets forth the non-GAAP financial measures we monitor.

| Three Months Ended June 30, |  | Six Months Ended June 30,
(in thousands, except percentages) | 2023 |  | 2022 |  | 2023 |  | 2022
Adjusted gross profit (1) | $ | 567 |  |  | $ | 1,569 |  |  | 1,181 |  |  | 3,386 |
Adjusted gross margin (1) | 16.3 | % |  | 28.6 | % |  | 14.3 | % |  | 27.6 | %
Adjusted EBITDA (2) | $ | (5,217) |  |  | $ | (6,602) |  |  | $ | (10,816) |  |  | $ | (10,848) |

(1)Adjusted gross profit and adjusted gross margin are non-GAAP financial measures. We believe that adjusted gross profit and adjusted gross margin provide supplemental information with respect to gross profit and gross margin regarding ongoing performance. We define adjusted gross profit as net revenues less cost of revenue, adjusted to exclude one-time revenue adjustments, stock-based compensation and amortization of intangible assets. We define adjusted gross margin as adjusted gross profit as a percentage of net revenues.
(2)Adjusted EBITDA is a non-GAAP financial measure. We believe adjusted EBITDA provides helpful information with respect to operating performance as viewed by management, including a view of our business that is not dependent on (i) the impact of our capitalization structure and (ii) items that are not part of day-to-day operations. We define adjusted EBITDA as net loss plus (i) interest expense, (ii) income tax expense, (iii) depreciation, (iv) amortization, and further adjusted for (v) non-cash impairment, (vi) valuation adjustments and (vii) stock-based compensation expense.
27

Table of Contents
Reconciliation of Non-GAAP Financial Measures
The following tables set forth a reconciliation of the most directly comparable GAAP financial measure to each of the non-GAAP financial measures discussed above.

| Three Months Ended June 30, |  | Six Months Ended June 30,
(in thousands, except percentages) | 2023 |  | 2022 |  | 2023 |  | 2022
Gross profit | $ | 456 |  |  | $ | 1,520 |  |  | $ | 817 |  |  | $ | 3,291 |
Add back: Stock-based compensation | 111 |  |  | 49 |  |  | 364 |  |  | 95 |
Adjusted gross profit | $ | 567 |  |  | $ | 1,569 |  |  | $ | 1,181 |  |  | $ | 3,386 |
Adjusted gross margin | 16.3 | % |  | 28.6 | % |  | 14.3 | % |  | 27.6 | %

| Three Months Ended June 30, |  | Six Months Ended June 30,
(in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
Net loss | $ | (6,524) |  |  | $ | (17,071) |  |  | $ | (10,793) |  |  | $ | (31,988) |
Add back: Depreciation and amortization | 188 |  |  | 182 |  |  | 376 |  |  | 368 |
Add back: Interest expense | 553 |  |  | 273 |  |  | 1,090 |  |  | 654 |
EBITDA | (5,783) |  |  | (16,616) |  |  | (9,327) |  |  | (30,966) |
Add Back: Stock-based compensation | 1,462 |  |  | 706 |  |  | 2,824 |  |  | 1,270 |
Add Back: Impairment of digital currencies | — |  |  | 12,158 |  |  | 50 |  |  | 21,511 |
Add Back: Impairment of goodwill | 1,203 |  |  | — |  |  | 1,203 |  |  | — |
Less: Fair value adjustment for warrant liabilities | (3) |  |  | (2,682) |  |  | (256) |  |  | (2,469) |
Less: Gain on sale of digital assets | (2,096) |  |  | (168) |  |  | (5,310) |  |  | (194) |
Adjusted EBITDA | $ | (5,217) |  |  | $ | (6,602) |  |  | $ | (10,816) |  |  | $ | (10,848) |

28

Table of Contents
Components of Results of Operations
Revenue and Gross Profit
There are a number of factors that impact the revenue and margin profile of the product, service and technology offerings we provide, including, but not limited to, solution and technology complexity, technical expertise requiring the combination of products and types of services provided, as well as other elements that may be specific to a particular client solution.
Platform Revenue and Gross Profit
Our platform revenue consists of software subscriptions, application development services and support and application transactions, which are comprised of in-app advertising and PhunToken sales.
Subscription revenue is derived from software license fees, which are comprised of subscription fees from customers licensing our Software Development Kits (SDKs), that include access to our platform. Subscription revenue from SDK licenses gives the customer the right to access our location-based software platform.
Application development revenue is derived from development services around designing and building new applications or enhancing existing applications. Support revenue is comprised of support and maintenance fees for customer applications, software updates and technical support for application development services for a support term. From time to time, we may also provide professional services by outsourcing employees’ time and materials to customers.
We generate application transaction revenue by charging advertisers to deliver advertisements (ads) to users of mobile connected devices. Depending on the specific terms of each advertising contract, we generally recognize revenue based on the activity of mobile users viewing these ads. Fees from advertisers are commonly based on the number of ads delivered or views, clicks or actions by users on mobile advertisements delivered, and we recognize revenue at the time the user views, clicks or otherwise acts on the ad. We sell ads through several offerings: cost per thousand impressions and cost per click. In 2021, we commenced PhunToken sales. PhunToken is designed to reward consumers for their activity, such as watching branded videos, completing surveys and visiting points of interest. We recognize revenue related to PhunToken at time of delivery to a customer's ethereum-based wallet.
Platform gross profit is equal to subscriptions and services revenue less the cost of personnel and related costs for our support and professional services employees, external consultants, stock-based compensation and allocated overhead. Costs associated with our development and project management teams are generally recognized as incurred. Costs directly attributable to the development or support of applications relating to subscription customers are included in cost of sales, whereas costs related to the ongoing development and maintenance of our software platform are expensed in research and development. Furthermore, gross profit related to application transactions is equal to application transaction revenue less cost of revenue associated with application transactions, which is impacted by the cost of advertising traffic we pay to our suppliers, the amount of traffic which we can purchase from those suppliers and ethereum blockchain fees paid to deliver PhunToken.
As a result, platform gross profit may fluctuate from period to period.
Hardware Revenue and Gross Profit
We acquired Lyte in October 2021. Revenue from Lyte is primarily derived from the sale of high-performance personal computers. Lyte computers are sold with a variety of pre-packaged solutions, as well as customizable solutions selected by our customers. A majority of Lyte's customers pay us via credit card payments, which is managed through a third- party processor. We recognize revenue at the time a completed unit ships from our facility.
Hardware gross profit is equal to hardware revenue less the costs associated with the assembly of computers. Hardware gross profit is impacted by the costs that we pay for parts incorporated into a Lyte computer system, as well as labor costs of our employees directly attributable to building computer systems and shipping. Demand may exceed available supply at times, which may hamper our ability to deliver computer systems in a timely manner and may increase the costs at which we can obtain inventory needed for computer builds. Customizable solutions we offer our customers may also vary from time to time. As a result, computer hardware revenue and gross profit may fluctuate from period to period. Although we plan to invest in Lyte for future growth, we may experience revenue and gross profit fluctuations as a result of seasonality.
29

Table of Contents
Gross Margin
Gross margin measures gross profit as a percentage of revenue. Gross margin is generally impacted by the same factors that affect changes in the mix of platform and hardware revenue.
Operating Expenses
Our operating expenses include sales and marketing expenses, general and administrative expenses, research and development expenses, depreciation and amortization of acquired intangible assets. Personnel costs are the most significant component of operating expenses and consist of salaries, benefits, bonuses, stock-based compensation and, in sales and marketing expense, commissions.
Sales and Marketing Expense. Sales and marketing expense is comprised of compensation, commission expense, variable incentive pay and benefits related to sales personnel, along with travel expenses, other employee related costs, including stock-based compensation and expenses related to marketing programs and promotional activities. Our sales and marketing expense may increase in absolute dollars as we increase our sales and marketing organizations as we plan to increase revenue but may fluctuate as a percentage of our total revenue from period to period.
General and Administrative Expense. General and administrative expense is comprised of compensation and benefits of administrative personnel, including variable incentive pay and stock-based compensation, bad debt expenses and other administrative costs such as facilities expenses, professional fees and travel expenses. We incur general and administrative expenses as a result of operating as a public company, including expenses related to compliance with the rules and regulations of the SEC and listing standards of Nasdaq, additional insurance expenses, investor relations activities and other administrative and professional services, including, but not limited to legal and audit related expenses. We also expect to increase the size of our general and administrative function to support the growth of our business. As a result, our general and administrative expenses may increase in absolute dollars but may fluctuate as a percentage of our total revenue from period to period.
Research and Development Expense. Research and development expenses consist primarily of employee compensation costs and overhead allocation. We believe that continued investment in our platform is important for our growth. As a result, our research and development expenses may increase in absolute dollars as our business grows but may fluctuate as a percentage of revenue from period to period.
Impairment of Goodwill. Goodwill impairment consists of non-cash impairment charges related to goodwill. We review goodwill for impairment annually on October 1 and more frequently if events or changes in circumstances indicate an impairment may exist. If the carrying value of the reporting unit continues to exceed its fair value, the fair value of the Company’s goodwill is calculated and an impairment charge equal to the excess is recorded.
Interest Expense
Interest expense includes interest related to our outstanding debt, including amortization of discounts and deferred issuance costs.
Refer to Note 6 "Debt" in the notes to the condensed consolidated financial statements included Part I, Item 1 of this Quarterly Report on Form 10-Q for more information on our debt offerings.
We also may seek additional debt financing to fund the expansion of our business or to finance strategic acquisitions in the future, which may have an impact on our interest expense.
30

Table of Contents
Results of Operations
Net Revenues

| Three Months Ended June 30, |  | Change
(in thousands, except percentages) | 2023 |  | 2022 |  | Amount |  | %
Net Revenues |  |  |  |  |  |  |
Platform revenue | $ | 1,295 |  |  | $ | 1,628 |  |  | $ | (333) |  |  | (20.5) | %
Hardware revenue | 2,192 |  |  | 3,857 |  |  | (1,665) |  |  | (43.2) | %
Net revenues | $ | 3,487 |  |  | $ | 5,485 |  |  | $ | (1,998) |  |  | (36.4) | %
Platform revenue as percentage of total revenue | 37.1 | % |  | 29.7 | % |  |  |  |
Hardware revenue as percentage of total revenue | 62.9 | % |  | 70.3 | % |  |  |  |

| Six Months Ended June 30, |  | Change
(in thousands, except percentages) | 2023 |  | 2022 |  | Amount |  | %
Net Revenues |  |  |  |  |  |  |
Platform revenue | $ | 2,640 |  |  | $ | 4,120 |  |  | $ | (1,480) |  |  | (35.9) | %
Hardware revenue | 5,594 |  |  | 8,143 |  |  | (2,549) |  |  | (31.3) | %
Net revenues | $ | 8,234 |  |  | $ | 12,263 |  |  | $ | (4,029) |  |  | (32.9) | %
Platform revenue as percentage of total revenue | 32.1 | % |  | 33.6 | % |  |  |  |
Hardware revenue as percentage of total revenue | 67.9 | % |  | 66.4 | % |  |  |  |

Net revenues decreased $2.0 million, or 36.4%, for the three months ended June 30, 2023 compared to the corresponding period in 2022.
Platform revenue decreased $0.3 million, or (20.5)%, for the three months ended June 30, 2023 compared to the corresponding period in 2022, primarily due to PhunToken sales in 2022. We did not sell any PhunToken during the three months ended June 30, 2023.
Hardware revenue decreased by $1.7 million, or (43.2)%, for the three months ended June 30, 2023 compared to the corresponding period in 2022, as a result of lower orders and resulting shipments for Lyte computers.
Net revenues decreased $4.0 million, or (32.9)%, for the six months ended June 30, 2023 compared to the corresponding period in 2022.
Platform revenue decreased $1.5 million, or (35.9)%, for the six months ended June 30, 2023 compared to the corresponding period in 2022, primarily due to PhunToken sales of $1.5 million in 2022. We did not sell any PhunToken during the six months ended June 30, 2023.
Hardware revenue decreased by $2.5 million, or (31.3)%, for the six months ended June 30, 2023 compared to the corresponding period in 2022, as a result of lower order backlog as of December 31, 2022, as compared to December 31, 2021 and lower sales of Lyte computers in 2023, as compared to the prior year.
31

Table of Contents
Cost of Revenues, Gross Profit and Gross Margin

| Three Months Ended June 30, |  | Change
(in thousands, except percentages) | 2023 |  | 2022 |  | Amount |  | %
Cost of Revenues |  |  |  |  |  |  |
Platform revenue | $ | 759 |  |  | $ | 572 |  |  | $ | 187 |  |  | 32.7 | %
Hardware revenue | 2,272 |  |  | 3,393 |  |  | (1,121) |  |  | (33.0) | %
Total cost of revenues | $ | 3,031 |  |  | $ | 3,965 |  |  | $ | (934) |  |  | (23.6) | %
Gross Profit |  |  |  |  |  |  |
Platform revenue | $ | 536 |  |  | $ | 1,056 |  |  | $ | (520) |  |  | (49.2) | %
Hardware revenue | (80) |  |  | 464 |  |  | (544) |  |  | (117.2) | %
Total gross profit | $ | 456 |  |  | $ | 1,520 |  |  | $ | (1,064) |  |  | (70.0) | %
Gross Margin |  |  |  |  |  |  |
Platform revenue | 41.4 | % |  | 64.9 | % |  |  |  |
Hardware revenue | (3.6) | % |  | 12.0 | % |  |  |  |
Total gross margin | 13.1 | % |  | 27.7 | % |  |  |  |

| Six Months Ended June 30, |  | Change
(in thousands, except percentages) | 2023 |  | 2022 |  | Amount |  | %
Cost of Revenues |  |  |  |  |  |  |
Platform revenue | $ | 2,030 |  |  | $ | 1,639 |  |  | $ | 391 |  |  | 23.9 | %
Hardware revenue | 5,387 |  |  | 7,333 |  |  | (1,946) |  |  | (26.5) | %
Total cost of revenues | $ | 7,417 |  |  | $ | 8,972 |  |  | $ | (1,555) |  |  | (17.3) | %
Gross Profit |  |  |  |  |  |  |
Platform revenue | 610 |  |  | $ | 2,481 |  |  | $ | (1,871) |  |  | (75.4) | %
Hardware revenue | 207 |  |  | $ | 810 |  |  | $ | (603) |  |  | (74.4) | %
Total gross profit | $ | 817 |  |  | $ | 3,291 |  |  | $ | (2,474) |  |  | (75.2) | %
Gross Margin |  |  |  |  |  |  |
Platform revenue | 23.1 | % |  | 60.2 | % |  |  |  |
Hardware revenue | 3.7 | % |  | 9.9 | % |  |  |  |
Total gross margin | 9.9 | % |  | 26.8 | % |  |  |  |

Total gross profit decreased $1.1 million, or 70.0%, three months ended June 30, 2023 compared to the corresponding period in 2022, as a result of the revenue items described above, as well as a $0.3 million charge recorded for obsolete Lyte inventory components.
Total gross profit decreased $2.5 million, or 75.2%, for the six months ended June 30, 2023 compared to the corresponding period of 2022, as a result of the revenue items and Lyte inventory charge described above. Further decreases in gross profit are attributable to a $0.2 million increase in stock-based compensation expense and $0.2 million in less gross margin as a result of a lower transactional revenue.
32

Table of Contents
Operating Expenses

| Three Months Ended June 30, |  | Change
(in thousands, except percentages) | 2023 |  | 2022 |  | Amount |  | %
Operating expenses |  |  |  |  |  |  |
Sales and marketing | $ | 1,472 |  |  | $ | 1,928 |  |  | $ | (456) |  |  | (23.7) | %
General and administrative | 4,766 |  |  | 5,251 |  |  | (485) |  |  | (9.2) | %
Research and development | 1,212 |  |  | 1,876 |  |  | (664) |  |  | (35.4) | %
Impairment of goodwill | 1,203 |  |  | — |  |  | 1,203 |  |  | 100.0 | %
Total operating expenses | $ | 8,653 |  |  | $ | 9,055 |  |  | $ | (402) |  |  | (4.4) | %

| Six Months Ended June 30, |  | Change
(in thousands, except percentages) | 2023 |  | 2022 |  | Amount |  | %
Operating expenses |  |  |  |  |  |  |
Sales and marketing | $ | 2,600 |  |  | $ | 3,413 |  |  | $ | (813) |  |  | (23.8) | %
General and administrative | 9,478 |  |  | 9,556 |  |  | (78) |  |  | (0.8) | %
Research and development | 2,984 |  |  | 2,879 |  |  | 105 |  |  | 3.6 | %
Impairment of goodwill | 1,203 |  |  | — |  |  | 1,203 |  |  | 100.0 | %
Total operating expenses | $ | 16,265 |  |  | $ | 15,848 |  |  | $ | 417 |  |  | 2.6 | %

Sales and Marketing
Sales and marketing expense decreased $0.5 million, or (23.7)%, for the three months ended June 30, 2023 compared to the corresponding period of 2022, primarily due to a decrease in marketing related expenditures for Lyte.
Sales and marketing expense decreased $0.8 million, or (23.8)%, for the six months ended June 30, 2023 compared to the corresponding period of 2022, primarily due to a decrease in marketing related expenditures for Lyte.
General and Administrative
General and administrative expense decreased $0.5 million, or 9.2%, for the three months ended June 30, 2023 compared to the corresponding period of 2022, due to a $0.8 decrease in compensation related expenses, mainly related to a decrease in bonus accrual and $0.4 million decrease in legal fees. These decreases were partially offset by a $0.7 million increase in stock-based compensation expense.
General and administrative expense decreased $0.1 million, or (0.8)%, for the six months ended June 30, 2023 compared to the corresponding period of 2022, due to a $0.7 million decrease in compensation related expenses, as described above and $0.7 million decrease in professional fees for legal expenses and consultants. These decreases were mostly offset by a $1.0 million increase in stock-based compensation expense and $0.3 million in facility related expenses.
Research and Development
Research and development expense decreased $0.7 million, or (35.4)%, for the three months ended June 30, 2023 compared to the corresponding period of 2022, as a result of a $0.4 million decrease in compensation expenses, mainly related to an adjustment to the Company's bonus accrual and $0.3 million for recruiting related expenses and contract labor.
Research and development expense increased $0.1 million, or 3.6%, for the six months ended June 30, 2023 compared to the corresponding period of 2022. There was no individual expense category experienced a significant change.
Impairment of Goodwill
We recorded an impairment of goodwill of $1.2 million related to the Lyte operating segment of our business for the three months ended June 30, 2023. Refer to Note 3 "Supplemental Information" of the notes to the condensed consolidated
33

Table of Contents
financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for further discussion on our goodwill impairment.
34

Table of Contents
Other expense

| Three Months Ended June 30, |  |
(in thousands, except percentages) | 2023 |  | 2022 |  |  |  |
Other income (expense) |  |  |  |  |  |  |
Interest expense | $ | (553) |  |  | $ | (273) |  |  |  |  |
Impairment of digital assets | — |  |  | (12,158) |  |  |  |  |
Gain on sale of digital assets | 2,096 |  |  | 168 |  |  |  |  |
Fair value adjustment of warrant liability | 3 |  |  | 2,682 |  |  |  |  |
Other income | 127 |  |  | 45 |  |  |  |  |
Total other income (expense) | $ | 1,673 |  |  | $ | (9,536) |  |  |  |  |

| Six Months Ended June 30, |  |
(in thousands, except percentages) | 2023 |  | 2022 |  |  |  |
Other income (expense) |  |  |  |  |  |  |
Interest expense | $ | (1,090) |  |  | $ | (654) |  |  |  |  |
Impairment of digital assets | (50) |  |  | (21,511) |  |  |  |  |
Gain on sale of digital assets | 5,310 |  |  | 194 |  |  |  |  |
Fair value adjustment of warrant liability | 256 |  |  | 2,469 |  |  |  |  |
Other income | 229 |  |  | 71 |  |  |  |  |
Total other income (expense) | $ | 4,655 |  |  | $ | (19,431) |  |  |  |  |

During the three and six months ended June 30, 2023, we recorded other income of $1.7 million and $4.7 million, respectfully, primarily as a result of realized gains on the sales of our bitcoin holdings.
During the three and six months ended June 30, 2022, we recorded other expenses of $9.5 million and $19.4 million, respectively, primarily as a result of impairment charges related to our digital asset holding and warrant fair value adjustments.
Refer to Note 5, "Digital Assets," of the notes to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for further discussion regarding our digital asset holdings.
35

Table of Contents
Liquidity and Capital Resources
As of June 30, 2023, we held total cash of $1.1 million, all of which was held in the United States. We have a history of operating losses and negative operating cash flows. As we continue to focus on growing our revenues, we expect these trends to continue into the foreseeable future.
On February 1, 2022, we filed a Form S-3, which was subsequently declared effective by the SEC on February 9, 2022, pursuant to which we may issue up to $200 million in common stock, preferred stock, warrants and units. Contained therein, was a prospectus supplement pursuant to which we may sell up to $100 million of our common stock in an “at the market offering” pursuant to an At Market Issuance Sales Agreement we entered into with H.C. Wainwright & Co., LLC on January 31, 2022. As of June 30, 2023, 4,338,596 shares of our common stock have been sold for aggregate gross cash proceeds of $5.6 million.
On July 6, 2022, we entered into a note purchase agreement and completed the sale of an unsecured promissory note with an original principal amount of $12.8 million in a private placement (the "2022 Promissory Note"). After deducting all transaction fees paid by us at closing, net cash proceeds to us at closing were $11.8 million. No interest was to accrue on the 2022 Promissory Note. Beginning on November 1, 2022 and on the same day of each month thereafter until the 2022 Promissory Note is paid in full, we were required to make monthly amortization payments of approximately $1.6 million until the original maturity date of July 1, 2023, which was subject to adjustment for any payment deferrals we elected. On March 15, 2023, we entered into a waiver agreement with the holder of our 2022 Promissory Note, waiving the Payment Deferral Conditions, as defined, at that time, in the 2022 Promissory Note. For agreeing to waive the Payment Deferral Conditions, we agreed to compensate the noteholder an amount equal to 5% of the outstanding balance immediately before entering into the waiver agreement. In connection therewith, we elected to defer the monthly payments under the 2022 Promissory Note for the months of April, May, June and July 2023. As a result of our election to defer the monthly payments, the outstanding balance of the 2022 Promissory Note was increased by 1.85% on the first day of each month beginning on April 1, 2023 and concluding on July 1, 2023. The waiver fee and the additional principal was to be paid in connection with our monthly installment payments once the deferral period concluded. Beginning on August 1, 2023 and on the same day of each month thereafter, we were required to pay to the noteholder the new monthly amortization payment in the amount of approximately $1.8 million. On August 14, 2023, we entered into an amendment to the 2022 Promissory Note with the noteholder. The amendment extends the maturity date to June 1, 2024 and provides that effective August 1, 2023, we are required to make monthly amortization payments of at least $800 thousand commencing on August 31, 2023 until the 2022 Promissory Note is paid-in-full. We also granted the noteholder certain limited conversion rights, which if elected by the noteholder, would reduce the required monthly payment. The limited conversion rights are subject to advance payment and volume conditions. The amendment also provides that the outstanding balance shall accrue interest at a rate of 8% and payment deferrals are no longer permitted under the 2022 Promissory Note. Furthermore, the amendment removed the required payment of approximately $1.8 million that was due on August 1, 2023.
In July 2023, we implemented a plan to decrease our cash burn by reducing headcount and other operating expenditures. Subsequent to June 30, 2023, we also raised approximately $5.5 million in our at-the-market equity offering. Our future plans may include additional reductions to operating expenses, additional sales of our common stock in our at-the-market offering, and issuing additional shares of common stock, preferred stock, warrants or units pursuant to an effective shelf registration statement. Plans to generate cash sufficient to meet our capital requirements may include selling shares of our common stock in our "at the market" offering, and as of the date of this Report, shares of our common stock with a maximum aggregate offering price of up to $88.9 million may be sold pursuant to the sales agreement. We may also issue shares of our common stock, preferred stock, warrants and units in other offerings pursuant to our effective registration statement.
Our expectation that we will generate operating losses and negative operating cash flows in the future and the need for additional funding to support our planned operations raise substantial doubt regarding our ability to continue as a going concern. Management believes that our existing cash would not be sufficient to satisfy our operating cash needs for the year after the filing of this Quarterly Report on Form 10-Q, and substantial doubt exists about our ability to continue as a going concern for one year following the filing date of this Quarterly Report on Form 10-Q.
Our future capital requirements will depend on many factors, including our pace of growth, subscription renewal activity, the timing and extent of spend to support development efforts, the pace at which we can scale Lyte, the expansion of sales and marketing activities and the market acceptance of our products and services. We believe that it is likely we will in the future enter into arrangements to acquire or invest in complementary businesses, technologies and intellectual property rights. We may be required to seek additional equity or debt financing, or issue securities under our effective registration statement described above.
In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us, or at all. Furthermore, we are currently not in compliance with the Bid Price Requirement of the Nasdaq.
36

Table of Contents
Although the Company is attempting to regain compliance, there can be no assurance that we will regain compliance with the Bid Price Requirement or maintain compliance with other Nasdaq continued listing requirements. This may also affect our ability to raise additional funds and the liquidity of our common stock. If we are unable to raise additional capital when desired and/or on acceptable terms, our business, operating results and financial condition could be adversely affected.
The accompanying consolidated financial statements have been prepared assuming we will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the ordinary course of business.
The following table summarizes our cash flows for the periods presented:

| Six Months Ended June 30, |  |
(in thousands, except percentages) | 2023 |  | 2022 |  |  |  |
Consolidated cash flows |  |  |  |  |  |  |
Net cash used in operating activities | $ | (12,560) |  |  | $ | (14,989) |  |  |  |  |
Net cash provided by (used in) investing activities | $ | 15,381 |  |  | $ | (2,206) |  |  |  |  |
Net cash used in financing activities | $ | (3,719) |  |  | $ | (3,116) |  |  |  |  |

Operating Activities
The primary source of cash from operating activities is receipts from sales of our various product and service offerings to customers. The primary uses of cash from operating activities are payments to employees for compensation and related expenses, publishers and other vendors for the purchase of digital media inventory and related costs, payments to vendors for the costs of inventory related to the assembly and shipping of Lyte computers, sales and marketing expenses and general operating expenses.
We utilized $12.6 million of cash from operating activities during the six months ended June 30, 2023, resulting in a net loss of $10.8 million. The net loss included a gain on the sale of digital assets of $5.3 million and non-cash charges of $5.7 million, primarily consisting of stock-based compensation and impairment of goodwill. In addition, certain changes in our operating assets and liabilities resulted in a cash decrease of $2.2 million, primarily relating to a decrease in deferred revenue.
We utilized $15.0 million of cash from operating activities during the six months ended June 30, 2022, primarily resulting from a net loss of $32.0 million. The net loss included non-cash charges of $20.9 million, primarily consisting of impairment of digital assets, fair value adjustment of our outstanding warrant and stock-based compensation. In addition, certain changes in our operating assets and liabilities resulted in significant cash (decreases) as follows: $0.5 million from an increase in accounts payable and accrued expenses, as well as $(4.4) million from other working capital changes, primarily an increase in inventory purchases and decrease in deferred revenue.
Investing Activities
Investing activities for the six months ended June 30, 2023 and 2022 primarily consisted of the purchases and sales of digital assets and payments relating to the acquisition of Lyte Technology, Inc.
Financing Activities
Our financing activities during the six months ended June 30, 2023 consisted of payments on our 2022 Promissory Note of $4.3 million and $0.5 million for repurchases of shares of our common stock. We received $1.0 million in proceeds from the sale of our common stock. Refer to the notes to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for information on the Company's financing activities.
Our financing activities during the six months ended June 30, 2022 primarily consisted of payments on debt. We had payments on debt of $3.1 million, of which all were payments on the 2021 Promissory Note.
Contractual Obligations
Information set forth in Note 7, "Leases," in the notes to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated herein by reference.
37

Table of Contents
Off-Balance Sheet Arrangements
Through June 30, 2023, we did not have any off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K, such as the use of unconsolidated subsidiaries, structured finance, special purpose entities or variable interest entities.
Indemnification Agreements
In the ordinary course of business, we provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, solutions to be provided by the Company or from intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with directors and certain current and former officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of, or are related to, their status or service as directors, officers or employees.
Recent Accounting Pronouncements
Refer to Note 2, "Summary of Significant Accounting Policies," in the notes to the condensed consolidated financial statements included in Item I, Part I of this Quarterly Report on Form 10-Q for analysis of recent accounting pronouncements applicable to our business.
Summary of Significant Accounting Policies
Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues generated and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Except for the changes described in Note 2, "Summary of Significant Accounting Policies," in the notes to the condensed consolidated financial statements included in Item I, Part I of this Quarterly Report on Form 10-Q, there have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 31, 2023.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not applicable.
38

Table of Contents
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Certifying Officers (as defined below), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer (together, the “Certifying Officers”), we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Report.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in conjunction with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls
In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.
39

Table of Contents
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
The information set forth under the "Litigation" subheading in Note 8, "Commitments and Contingencies," in the notes to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated herein by reference.
Item 1A. Risk Factors
Important risk factors that could affect our operations and financial performance, or that could cause results or events to differ from current expectations, are described in Part I, Item 1A, "Risk Factors” of our Annual Report on Form 10-K filed with the SEC on March 31, 2023 for the year ended December 31, 2022 and the information set forth below or contained elsewhere in this Report. The risks and uncertainties described within our Form 10-K for the year ended December 31, 2022 and as set forth below are not the only risks we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that adversely affect our business or results of operations.
If we cannot meet the continued listing requirements of Nasdaq, the Nasdaq may delist our common stock, which would have an adverse impact on the trading volume, liquidity and market price of our common stock and would trigger a default under our 2022 Promissory Note.
Our common stock is currently listed on the Nasdaq Capital Market. On April 13, 2023, we were notified by the Nasdaq Stock Market LLC (the “Nasdaq”) that the closing bid price for our common stock had been below $1.00 for the last 30 consecutive business days and that the Company therefore is not in compliance with the minimum bid price requirement for continued inclusion on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). Under the Nasdaq Listing Rules, the Company has a period of 180 calendar days from the date of the notice, or October 10, 2023 (the "Compliance Date"), to regain compliance with the Bid Price Requirement. To regain compliance, the closing bid price of the Company’s common stock must be at least $1.00 for a minimum of ten consecutive business days prior to the Compliance Date.
We intend to monitor the closing bid price of our common stock and may, if appropriate, consider available options to regain compliance with the Bid Price Requirement. To regain compliance with Nasdaq listing standards we may have to implement a reverse stock split, subject to approval of our board of directors and stockholders. However, there can be no assurance that we will be able to regain compliance with the Bid Price Requirement or will otherwise be in compliance with other Nasdaq Listing Rules.
If our common stock ultimately were to be delisted for any reason, it could negatively impact us as it would likely reduce the liquidity and market price of our common stock; reduce the number of investors willing to hold or acquire our common stock; and negatively impact our ability to access equity markets and obtain financing. If our common stock were to be removed from listing on the Nasdaq (and our common stock were not to become listed on other specified stock exchanges), it would trigger a default under our 2022 Promissory Note, and the outstanding balance would be immediately due and payable in cash at the Mandatory Default Amount (as defined in the 2022 Promissory Note).
40

Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
The following table summarizes the Company's stock repurchase activity for the three months ended June 30, 2023:

Issuer Purchases of Common Stock
|  | Total Number of Shares Purchased |  | Average Price Paid per Common Share |  | Total Number of Shares Purchased as Part of Publicly Announced Programs (1) |  | Maximum Dollar Value of Shares That May Yet Be Purchased Under the Programs (in thousands) (1)
April 2023 |  | 45,000 |  |  | $ | 0.60 |  |  | 45,000 |  |  | $ | 4,498 |
May 2023 |  | — |  |  | $ | — |  |  | — |  |  | $ | 4,498 |
June 2023 |  | — |  |  | $ | — |  |  | — |  |  | $ | 4,498 |
Total quarter ended June 30, 2023 |  | 45,000 |  |  | $ | 0.60 |  |  | 45,000 |  |  | $ | 4,498 |

(1) | On January 5, 2023, our board of directors authorized and approved a stock repurchase program for the repurchase of outstanding shares of our common stock with an aggregate value of up to $5 million. The authorization permits us to repurchase shares of our common stock from time-to-time through open market repurchases at prevailing market prices, in accordance with federal securities laws. The stock repurchase plan is expected to be completed over the next twelve (12) months and may be amended or terminated at any time, in the sole discretion of our board of directors. The exact means, number and timing of stock repurchases will depend on market conditions, applicable legal requirements and other factors.

Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
41

Table of Contents
Item 6. Exhibits
Unless otherwise noted, the exhibits listed on the accompanying Exhibit Index are filed or incorporated by reference (as stated therein) as part of this Quarterly Report on Form 10-Q.
EXHIBIT INDEX

Exhibit No. |  | Description
3.1 |  | Certificate of Incorporation of the Registrant (Incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K (File No. 001-37862), filed with the SEC on January 2, 2019).
3.2 |  | Amended and Restated Bylaws of the Registrant (Incorporated by reference to Exhibit 3.2 of the Registrant’s Form 8-K (File No. 001-37862), filed with the SEC on January 2, 2019).
10.1+ |  | Phunware, Inc. 2022 Inducement Plan (Incorporated by reference to Exhibit 10.1 of the Registrant's Form 8-K (File No. 001-37862), filed with the SEC on January 6, 2023).
10.2+ |  | Amended and Restated Employment Agreement by and between Phunware, Inc. and Matt Lull (Incorporated by reference to Exhibit 10.44 of the Registrant's Form 10-K (File No. 001-37862), filed with the SEC on March 31, 2023).
10.3+ |  | Amended and Restated Employment Agreement by and between Phunware, Inc. and Chris Olive (Incorporated by reference to Exhibit 10.43 of the Registrant's Form 10-K (File No. 001-37862), filed with the SEC on March 31, 2023).
10.4+ |  | Confidential Executive Employment Agreement by and between Phunware, Inc. and Troy Reisner (Incorporated by reference to Exhibit 10.1 of the Registrant's Form 8-K (File No. 001-37862), filed with the SEC on June 2, 2023).
10.5+ |  | Confidential Separation, Transition and General Release Agreement by and between Phunware, Inc. and Matt Aune (Incorporated by reference to Exhibit 10.1 of the Registrant's Form 8-K (File No. 001-37862), filed with the SEC on June 8, 2023).
10.6*+ |  | Phunware, Inc. 2023 Inducement Plan.
10.7* |  | Amendment to Promissory Note by and between Phunware, Inc. and Streeterville Capital, LLC.
31.1* |  | Certification of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)*
31.2* |  | Certification of the Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)*
32.1** |  | Certification of the Principal Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350*
101.INS |  | XBRL Instance Document*
101.SCH |  | XBRL Taxonomy Extension Schema*
101.CAL |  | XBRL Taxonomy Calculation Linkbase*
101.LAB |  | XBRL Taxonomy Label Linkbase*
101.PRE |  | XBRL Definition Linkbase Document*
101.DEF |  | XBRL Definition Linkbase Document*
104 |  | Cover Page Interactive Data File*

* Filed herewith
** Furnished herewith
+ Indicates a management contract or compensatory plan or arrangement
42

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

August 14, 2023 | Phunware, Inc.
| By: | /s/ Russell Buyse
|  | Name: | Russell Buyse
|  | Title: | Chief Executive Officer
|  |  | (Principal Executive Officer)

August 14, 2023 | By: | /s/ Troy Reisner
|  | Name: | Troy Reisner
|  | Title: | Chief Financial Officer
|  |  | (Principal Accounting and Financial Officer)

43